0000840715 CLEARONE INC --12-31 false Q3 2023 0000840715 2023-11-07 0000840715 2022-09-30 0000840715 2022-12-31 0000840715 2023-01-01 2023-09-30 0000840715 us-gaap:RetainedEarningsMember 2022-06-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-06-30 0000840715 us-gaap:RetainedEarningsMember 2023-06-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-06-30 0000840715 clro:EquityIncentivePlan2007TwoMember 2023-01-01 2023-09-30 0000840715 clro:EquityIncentivePlan2007TwoMember 2023-09-30 0000840715 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0000840715 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0000840715 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-09-30 0000840715 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0000840715 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0000840715 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0000840715 us-gaap:SellingAndMarketingExpenseMember 2022-07-01 2022-09-30 0000840715 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0000840715 us-gaap:CertificatesOfDepositMember 2023-09-30 0000840715 us-gaap:MutualFundMember 2023-09-30 0000840715 us-gaap:USTreasurySecuritiesMember 2023-09-30 0000840715 us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0000840715 us-gaap:FairValueInputsLevel3Member us-gaap:MutualFundMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel2Member us-gaap:MutualFundMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember 2023-09-30 0000840715 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0000840715 us-gaap:SellingAndMarketingExpenseMember 2023-07-01 2023-09-30 0000840715 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0000840715 clro:EquityIncentivePlan2007Member 2023-09-30 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2022-07-01 2022-09-30 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2023-07-01 2023-09-30 0000840715 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000840715 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000840715 clro:EuropeAndAfricaMember 2022-07-01 2022-09-30 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2022-07-01 2022-09-30 0000840715 srt:AmericasMember 2022-07-01 2022-09-30 0000840715 clro:VideoProductsMember 2022-07-01 2022-09-30 0000840715 clro:MicrophonesMember 2022-07-01 2022-09-30 0000840715 clro:AudioConferencingMember 2022-07-01 2022-09-30 0000840715 clro:EuropeAndAfricaMember 2023-07-01 2023-09-30 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2023-07-01 2023-09-30 0000840715 srt:AmericasMember 2023-07-01 2023-09-30 0000840715 clro:VideoProductsMember 2023-07-01 2023-09-30 0000840715 clro:MicrophonesMember 2023-07-01 2023-09-30 0000840715 clro:AudioConferencingMember 2023-07-01 2023-09-30 0000840715 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2023-09-30 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2023-01-01 2023-09-30 0000840715 us-gaap:ConvertibleDebtMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2019-12-17 2019-12-17 0000840715 us-gaap:CommonStockMember us-gaap:DividendDeclaredMember 2023-05-08 2023-05-08 0000840715 us-gaap:CommonStockMember us-gaap:DividendDeclaredMember 2023-05-08 0000840715 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0000840715 us-gaap:WarrantMember us-gaap:CommonStockMember 2019-12-17 0000840715 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0000840715 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-09-30 0000840715 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0000840715 clro:EquityIncentivePlan2007Member 2023-01-01 2023-09-30 0000840715 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember srt:MaximumMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember srt:MaximumMember 2019-12-17 2019-12-17 0000840715 us-gaap:CommonStockMember us-gaap:BeneficialOwnerMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember us-gaap:CommonStockMember 2019-12-17 0000840715 clro:EuropeAndAfricaMember 2023-01-01 2023-09-30 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2023-01-01 2023-09-30 0000840715 srt:AmericasMember 2023-01-01 2023-09-30 0000840715 clro:VideoProductsMember 2023-01-01 2023-09-30 0000840715 clro:MicrophonesMember 2023-01-01 2023-09-30 0000840715 clro:AudioConferencingMember 2023-01-01 2023-09-30 0000840715 2023-09-30 0000840715 stpr:FL srt:IndustrialPropertyMember 2023-09-30 0000840715 srt:OfficeBuildingMember stpr:UT 2023-09-30 0000840715 country:IN srt:OfficeBuildingMember 2023-09-30 0000840715 stpr:UT srt:WarehouseMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000840715 us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000840715 us-gaap:TradeNamesMember 2023-09-30 0000840715 clro:PatentsAndTechnologicalKnowHowMember 2023-09-30 0000840715 clro:ProprietarySoftwareMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000840715 us-gaap:OtherIntangibleAssetsMember 2023-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000840715 us-gaap:RetainedEarningsMember 2023-09-30 0000840715 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0000840715 us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0000840715 us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0000840715 us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0000840715 us-gaap:ConvertibleNotesPayableMember 2023-09-30 0000840715 us-gaap:FairValueInputsLevel1Member 2023-09-30 0000840715 us-gaap:FairValueInputsLevel2Member 2023-09-30 0000840715 us-gaap:FairValueInputsLevel3Member 2023-09-30 0000840715 2021-12-31 0000840715 us-gaap:BridgeLoanMember 2021-07-01 2021-07-02 0000840715 us-gaap:CommonStockMember 2021-09-12 0000840715 us-gaap:CommonStockMember 2021-09-12 2021-09-12 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-12-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000840715 us-gaap:RetainedEarningsMember 2021-12-31 0000840715 clro:SecuritiesPurchaseAgreementMember us-gaap:MajorityShareholderMember us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2022-01-04 0000840715 us-gaap:CommonStockMember 2023-09-30 0000840715 2022-01-01 2022-09-30 0000840715 clro:AudioConferencingMember 2022-01-01 2022-09-30 0000840715 clro:MicrophonesMember 2022-01-01 2022-09-30 0000840715 clro:VideoProductsMember 2022-01-01 2022-09-30 0000840715 srt:AmericasMember 2022-01-01 2022-09-30 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2022-01-01 2022-09-30 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2021-07-02 0000840715 clro:EuropeAndAfricaMember 2022-01-01 2022-09-30 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2021-07-01 2021-07-02 0000840715 2023-07-01 2023-09-30 0000840715 2022-07-01 2022-09-30 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2022-01-01 2022-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000840715 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-09-30 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000840715 us-gaap:RetainedEarningsMember 2022-09-30 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember 2022-01-04 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember 2022-01-04 2022-01-04 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-10-28 2022-10-28 0000840715 us-gaap:TradeNamesMember 2022-12-31 0000840715 clro:PatentsAndTechnologicalKnowHowMember 2022-12-31 0000840715 clro:ProprietarySoftwareMember 2022-12-31 0000840715 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-12-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000840715 us-gaap:RetainedEarningsMember 2022-12-31 0000840715 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-10-28 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-01-31 0000840715 srt:MinimumMember us-gaap:TradeNamesMember 2023-09-30 0000840715 srt:MaximumMember us-gaap:TradeNamesMember 2023-09-30 0000840715 clro:PatentsAndTechnologicalKnowHowMember srt:MinimumMember 2023-09-30 0000840715 clro:PatentsAndTechnologicalKnowHowMember srt:MaximumMember 2023-09-30 0000840715 srt:MinimumMember clro:ProprietarySoftwareMember 2023-09-30 0000840715 srt:MaximumMember clro:ProprietarySoftwareMember 2023-09-30 0000840715 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2023-09-30 0000840715 srt:MaximumMember us-gaap:OtherIntangibleAssetsMember 2023-09-30 0000840715 us-gaap:CommonStockMember 2023-08-01 2023-08-01 0000840715 us-gaap:CommonStockMember 2023-08-01 0000840715 us-gaap:DividendDeclaredMember us-gaap:CommonStockMember 2023-08-01 xbrli:shares xbrli:pure utr:D utr:sqft iso4217:USD iso4217:USD xbrli:shares

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

Form 10-Q

 

(Mark One)

 

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period _______ to _______

 

Commission file number:001-33660

CLEARONE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

87-0398877

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. employer identification number)

 

 

 

5225 Wiley Post Way, Suite 500, Salt Lake City, Utah

 

84116

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (801) 975-7200

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading Symbol(s)

  

Name of each exchange on which registered

Common Stock, $0.001

 

CLRO

 

The NASDAQ Capital Market

 

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Larger Accelerated Filer ☐

Accelerated Filer ☐ 

Non-Accelerated Filer ☒

Smaller Reporting Company ☒

 

Emerging Growth Company ☐ 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes ☐ No


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

The number of shares of ClearOne common stock outstanding as of November 7, 2023 was 23,960,684. 


 CLEARONE, INC.

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2023

 

INDEX​



PART I - FINANCIAL INFORMATION



Item 1. Financial Statements 3




Unaudited Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 3




Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022 4




Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 5




Unaudited Notes to Condensed Consolidated Financial Statements 7



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19



Item 3. Quantitative and Qualitative Disclosures About Market Risk 26



Item 4. Controls and Procedures 26




PART II - OTHER INFORMATION



Item 1. Legal Proceedings 27



Item 1A. Risk Factors 27



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27



Item 3. Defaults Upon Senior Securities 27



Item 4. Mine Safety Disclosures 27



Item 5. Other Information 27



Item 6. Exhibits 28

 

 

 

  

CLEARONE, INC

(Dollars in thousands, except par value)

 

 

 

September 30, 2023

 

 

December 31, 2022

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

13,694

 

 

$

984

 

Current marketable securities

5,698


—
Legal settlement receivable

—


55,000

Receivables, net of allowance of $326

 

 

3,874

 

 

 

3,603

 

Inventories, net

 

 

8,664

 

 

 

8,961

 

Income tax receivable

6,381


1,071

Prepaid expenses and other assets

 

 

3,776

 

 

 

7,808

 

Total current assets

 

 

42,087

 

 

 

77,427

 

Long-term marketable securities

583


—

Long-term inventories, net

 

 

2,870

 

 

 

2,707

 

Property and equipment, net

 

 

590

 

 

 

383

 

Operating lease - right of use assets, net

 

 

1,081

 

 

 

1,047

 

Intangibles, net

 

 

1,794

 

 

 

2,071

 

Other assets

 

 

112

 

 

 

115

 

Total assets

 

$

49,117

 

 

$

83,750

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,759

 

 

$

1,284

 

Accrued liabilities

 

 

2,340

 

 

 

3,041

 

Deferred product revenue

 

 

38

 

 

 

63

 

Short-term debt

1,204


3,732

Total current liabilities

 

 

5,341

 

 

 

8,120

 

Operating lease liability, net of current

 

 

755

 

 

 

492

 

Other long-term liabilities

 

 

1,008

 

 

 

1,008

 

Total liabilities

 

 

7,104

 

 

 

9,620

 

 

 

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

 

 

 

 

Common stock, par value $0.001, 50,000,000 shares authorized, 23,960,684 and  23,955,767 shares issued and outstanding, respectively

 

 

24

 

 

 

24

 

Additional paid-in capital

 

 

46,015

 

 

 

74,910

 

Accumulated other comprehensive loss

 

 

(308

 )

 

 

(288

)

Accumulated deficit

 

 

(3,718

 )

 

 

(516

)

Total shareholders' equity

 

 

42,013

 

 

 

74,130

 

Total liabilities and shareholders' equity

 

$

49,117

 

 

$

83,750

 

 

See accompanying notes

 

 

CLEARONE, INC.

COMPREHENSIVE LOSS

(Dollars in thousands, except per share amounts)

 

 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Revenue

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184

Cost of goods sold 

 

 

3,273

 

 

 

3,694

 



9,771


12,991

Gross profit

 

 

1,616

 

 

 

2,570

 



4,779


8,193

 

 

 

 

 

 

 

 

 









Operating expenses:

 

 

 

 

 

 

 

 









Sales and marketing

 

 

1,119

 

 

 

1,151

 



3,634


4,273

Research and product development

 

 

889

 

 

 

876

 



2,805


3,406

General and administrative

 

 

1,097

 

 

 

1,673

 



3,373


5,146

Total operating expenses

 

 

3,105

 

 

 

3,700

 



9,812


12,825

 

 

 

 

 

 

 

 

 









Operating loss

 

 

(1,489

 )

 

 

(1,130

)



(5,033 )

(4,632
 )

 

 

 

 

 

 

 

 

 









Interest expense

(86)

(90 )

(469 )

(285 )

Other income (loss), net

 

 

243

 

 

(3

 )

2,346


1,505

 

 

 

 

 

 

 

 

 









Loss before income taxes

 

 

(1,332

 )

 

 

(1,223

 )

(3,156 )

(3,412 )

 

 

 

 

 

 

 

 

 









Provision for income taxes

 

 

19

 

 

 

25

 



46


60

 

 

 

 

 

 

 

 

 









Net loss

 

$

(1,351

 )

 

$

(1,248

 )
$ (3,202 ) $ (3,472 )

 

 

 

 

 

 

 

 

 









Basic weighted average shares outstanding

 

 

23,960,313

 

 

 

23,952,555

 



23,957,311


23,933,033

Diluted weighted average shares outstanding

 

 

23,960,313

 

 

 

23,952,555

 



23,957,311


23,933,033

 

 

 

 

 

 

 

 

 









Basic loss per share

 

$

(0.06

 )

 

$

(0.05

 )
$ (0.13 )
$ (0.15 )

Diluted loss per share

 

$

(0.06

 )

 

$

(0.05

)


$ (0.13 )
$ (0.15 )

 

 

 

 

 

 

 

 

 









Comprehensive loss:

 

 

 

 

 

 

 

 









Net loss

 

$

(1,351

 )

 

$

(1,248

 )
$ (3,202 )
$ (3,472 )

Unrealized loss on available-for-sale securities, net of tax

 

 

(31

 )

 

 

—

(17 )

(2
 )

Change in foreign currency translation adjustment

 

 

(7

 )

 

 

(22

 )

(3
 )

(45
 )

Comprehensive loss

 

$

(1,389

 )

 

$

(1,270

)


$ (3,222 )
$ (3,519 )

 

See accompanying notes

 

 

CLEARONE, INC.

(Dollars in thousands, except per share amounts)

 

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(3,202

 )

 

$

(3,472

 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization expense

 

 

709

 

 

 

2,390

 

Amortization of right-of-use assets

 

 

306

 

 

 

449

 

Share-based compensation expense

 

 

80

 

 

 

90

 

Change of inventory to net realizable value

 

 

105

 

 

 

221

 

    Gain recognized on Paycheck Protection Plan Loan forgiveness

—


(1,528 )
    Gain (loss) on disposal of assets and sale of marketable securities

(12 )

—

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Receivables

 

 

(271

 )

 

 

868

Legal settlement receivable



55,000


—

Inventories

 

 

29

 

 

 

710

 

Prepaid expenses and other assets

 

 

4,035

 

 

2,051

Accounts payable

 

 

475

 

 

(3,336

 )

Accrued liabilities

 

 

(448

 )

 

 

(54

 )

Income taxes receivable

 

 

(5,310

 )

 

 

—

Deferred product revenue

 

 

(25

 )

 

 

19

Operating lease liabilities

 

 

(328

 )

 

 

(468

 )

Net cash provided by (used in) operating activities

 

 

51,143

 

 

(2,060

 )

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(372

 )

 

 

(17

 )

Purchase of intangibles

 

 

(111

 )

 

 

(93

 )

Capitalized patent defense costs

 

 

—

 

 

(642

 )

Proceeds from maturities and sales of marketable securities

 

 

3,094

 

 

 

3,008

 

Purchases of marketable securities

(9,389 )

—

Net cash provided by (used in) investing activities

 

 

(6,778

 )

 

 

2,256

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Dividend payment

(28,979 )

—

Net proceeds from equity-based compensation programs 

 

 

4

 

 

 

3

 

Paycheck Protection Program loan refund upon full forgiveness net of loan payments



—


768

Principal payments of debt



(2,675 )

(540 )

Net cash provided by (used in) financing activities

 

 

(31,650

 )

 

 

231

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(5

 )

 

 

(48

)

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents 

 

 

12,710

 

 

379

Cash and cash equivalents at the beginning of the period

 

 

984

 

 

 

1,071

 

Cash and cash equivalents at the end of the period 

 

$

13,694

 

$

1,450

 

  

See accompanying notes

 

 

 CLEARONE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands, except per share amounts)

 

The following is a summary of supplemental cash flow activities:

 

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

Cash paid for income taxes

 

$

6,650

 

 

$

68

 

Cash paid for interest 311 140

 

See accompanying notes

 


CLEARONE, INC.

(Unaudited - Dollars in thousands, except per share amounts)

  

1. Business Description, Basis of Presentation and Significant Accounting Policies

 

Business Description:

 

ClearOne, Inc., together with its subsidiaries (collectively, “ClearOne” or the “Company”), is a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.

 

Basis of Presentation:

 

The fiscal year for ClearOne is the twelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated. 

 

These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of September 30, 2023 and December 31, 2022, the results of operations for the three and nine months ended September 30, 2023 and 2022, and the cash flows for the nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 and 2022 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC. 

 

Significant Accounting Policies:

 

The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2022. There have been no changes to these policies during the quarter ended September 30, 2023 that are of significance or potential significance to the Company.


Recent accounting pronouncements: 


In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. CECL estimates of expected credit losses on trade receivables over their life will be required to be recorded at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The Company adopted the standard in its first quarter of 2023. There was no material impact on the results of operations.

 

The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

  

Liquidity:

 

As of September 30, 2023, our cash and cash equivalents were approximately $13,694 compared to $984 as of December 31, 2022. Our working capital was $36,746 as of September 30, 2023. Net cash provided by operating activities was $51,143 for the nine months ended September 30, 2023, an increase of $53,203 compared to $2,060 of cash used in operating activities for the nine months ended September 30, 2022.  The Company believes, although there can be no assurance, that the current cash position and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least November 8, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing on favorable terms or at all. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.

 

2. Revenue Information

 

The following table disaggregates the Company’s revenue into primary product groups:

 

 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Audio conferencing

 

$

1,867

 

 

$

3,201

 


$ 6,484

$ 9,655

Microphones

 

 

2,355

 

 

 

2,475

 



6,239


8,525

Video products

 

 

667

 

 

 

588

 



1,827


3,004

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184

 

The following table disaggregates the Company’s revenue into major regions: 


 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

North and South America 

 

$

2,400

 

 

$

3,251

 


$ 7,353

$ 10,211

Asia Pacific (includes Middle East, India and Australia)

 

 

2,058

 

 

 

2,018

 



5,426


6,560

Europe and Africa

 

 

431

 

 

 

995

 



1,771


4,413

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)


3. Loss Per Share

 

Loss per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options, warrants and the convertible portion of senior convertible notes are considered to be potential common stock. The computation of diluted earnings (loss) per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. 

 

Basic earnings (loss) per common share is the amount of net earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted earnings (loss) per common share is the amount of earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect. 


The following table sets forth the computation of basic and diluted earnings (loss) per common share:

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Numerator:

















Net loss


$ (1,351 )
$ (1,248 )
$ (3,202 )
$ (3,472)

Denominator:

















Basic weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

Dilutive common stock equivalents using treasury stock method



—


—


—


—

Diluted weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

 

















Basic loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

Diluted loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

 

















Weighted average options, warrants and convertible portion of senior convertible notes outstanding



6,294,994


6,694,433


6,316,137


6,896,803

Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation



6,294,994


6,694,433


6,316,137


6,896,803

 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

4. Marketable Securities

 

The Company has classified its marketable securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned.

 

The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of securities as of September 30, 2023 were as follows:


 

 

Amortized cost

 

 

Gross unrealized holding gains

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities
$ 3,281

$ —

$ (3 )
$ 3,278
Mutual funds

1,169


2


—

1,171
Certificates of deposit

859


—


—


859

Corporate bonds and notes

 

$

989

 

 

$

—

 

 

$

(16

 )

 

$

973

 

Total available-for-sale securities

 

$

6,298

 

 

$

2

 

 

$

(19

 )

 

$

6,281

 

 

There were no available-for sale securities as of December 31, 2022.


 

 

Amortized cost

 

 

Estimated fair value

 

Due within one year

 

$

5,715

 

 

$

5,698

 

Due after one year through five years

 

 

583

 

 

 

583

 

Due after five years

 

 

—

 

 

 

—

 

Total available-for-sale securities

 

$

6,298

 

 

$

6,281

 

 

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)


Debt securities in an unrealized loss position as of September 30, 2023 were not deemed impaired at acquisition and subsequent declines in fair value are not deemed attributed to declines in credit quality. Management believes that it is more likely than not that the securities will receive a full recovery of par value, although there can be no assurance that such recovery will occur. The available-for-sale marketable securities with continuous gross unrealized loss position for less than 12 months and 12 months or greater and their related fair values were as follows: 

 

 

 

Less than 12 months

 

 

More than 12 months

 

 

Total

 

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

As of September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities

 

$

3,278

 

 

$

(3

 )

 

$

—

 

 

$

—

 

 

$

3,278

 

 

$

(3

 )

Corporate bonds and notes

 

 

973

 

 

 

(16

 )

 

 

—

 

 

 

—

 

 

 

973

 

 

 

(16

 )

Total

 

$

4,251

 

 

$

(19

 )

 

$

—

 

 

$

—

 

 

$

4,251

 

 

$

(19

 )


5. Intangible Assets

 

Intangible assets as of September 30, 2023 and December 31, 2022 consisted of the following:

 

 

 

Estimated useful lives (years)

 

 

September 30, 2023

 

 

December 31, 2022

 

Tradename

 

 5

to

7

 

 

$

555

 

 

$

555

 

Patents and technological know-how

 

10

to

20

 

 

 

7,164

 

 

 

7,053

 

Proprietary software

 

 3

to

15

 

 

 

2,981

 

 

 

2,981

 

Other

 

 3

to

5

 

 

 

323

 

 

 

323

 

Total intangible assets

 

 

 

 

 

 

 

11,023

 

 

 

10,912

 

Accumulated amortization

 

 

 

 

 

 

 

(9,229

 )

 

 

(8,841

)

Total intangible assets, net

 

 

 

 

 

 

$

1,794

 

 

$

2,071

 

 

The amortization of intangible assets for the three and nine months ended September 30, 2023 and 2022 was as follows: 

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Amortization of intangible assets


$ 141

$ 686

$ 388

$ 2,038

 

The estimated future amortization expense of intangible assets is as follows:

 

Years ending December 31,

 

Amount

 

2023 (Remainder)

 

$

129

 

2024

 

 

255

 

2025

 

 

194

 

2026

 

 

193

 

2027

 

 

63

 

Thereafter

 

 

960

 

Total

 

$  

1,794

 

 

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

6. Inventories

 

Inventories, net of reserves, as of September 30, 2023 and December 31, 2022 consisted of the following:  

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Current:

 

 

 

 

 

 

 

 

Raw materials

 

$

3,210

 

 

$

4,499

 

Finished goods

 

 

5,454

 

 

 

4,462

 

 

 

$

8,664

 

 

$

8,961

 

 

 

 

 

 

 

 

 

 

Long-term:

 

 

 

 

 

 

 

 

Raw materials

 

$

1,302

 

 

$

1,068

 

Finished goods

 

 

1,568

 

 

 

1,639

 

 

 

$

2,870

 

 

$

2,707

 

  

Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales. We expect to sell the above inventory, net of reserves, at or above the stated cost and believe that no loss will be incurred on its sale, although there can be no assurance of the timing or amount of any sales. 

 

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory for three and nine months ended September 30, 2023 and 2022 was as follows:   

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory


$ 3

$ 194

$ 105

$ 221

 

7. Leases

 

Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods. 

 

Rent expense for three and nine months ended September 30, 2023 and 2022 was as follows: 

 

 

 

Three months ended September 30,


 

Nine months ended September 30,

 

 

2023

 

 

2022


 

2023

2022

Rent expense

 

$

110

 

 

$

169


 

$ 369

$ 518

The Company occupies a 1,350 square-foot facility in Gainesville, Florida under the terms of an operating lease expiring in February 2028. The Gainesville facility is used primarily to support the Company's research and development activities. 

 

The Company occupies a 9,402 square-foot facility in Salt Lake City, Utah under the terms of an operating lease expiring in February 2028. The facility supports the Company's principal administrative, sales, marketing, customer support, and research and product development activities. 

 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)


The Company occupies a 6,175 square-foot facility in Chennai, India under the terms of an operating lease expiring in August 2024. This facility supports the Company's administrative, marketing, customer support, and research and product development activities. The Company is planning to renew the lease.

 

The Company occupies a 40,000 square-foot warehouse in Salt Lake City, Utah under the terms of an operating lease expiring in April 2025, which serves as the Company's primary inventory fulfillment center.  


Supplemental cash flow information related to leases was as follows: 

 

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

Cash paid for amounts included in the measurement of lease liabilities

 



 

 



 

Operating cash flows from operating leases
$ 378
$ 531
Right-of-use assets obtained in exchange for lease obligations:







Operating leases
$ 341

$ —

 

Supplemental balance sheet information related to leases was as follows:

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Operating lease right-of-use assets

 

$

 1,081

 

 

$

 1,047

 


 








Current portion of operating lease liabilities, included in accrued liabilities
$ 390

$ 641

Operating lease liabilities, net of current portion

 

 

755

 

 

 

492

 

Total operating lease liabilities

 

$

1,145

 

 

$

1,133

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term for operating leases (in years) 

3.56


2.12
Weighted average discount rate for operating leases

6.43 %

5.93 %

  

The following represents maturities of operating lease liabilities as of September 30, 2023:

 

Years ending December 31,

 

 

 

 

2023 (Remainder)

 

$

114

 

2024

 

 

439

 

2025

 

 

272

 

2026

 

 

210

 

2027

 

 

216

 

Thereafter

38

Total lease payments

 

 

1,289

 

Less: Imputed interest

 

 

(144

 )

Total

 

$

1,145

 


 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

 

8. Shareholders' Equity

 

 

 

Three months ended September 30,

 


Nine Months Ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

46,003

 

 

$

74,885

 


$ 74,934

$ 72,817

Dividends paid

 


—

 


—

 


(28,979 )
—
Issuance of common stock and warrants, net

 —


—


—


2,000

Share-based compensation expense

 

 

33

 

 

 

24

 



80


90

Proceeds from employee stock purchase plan

 

 

3

 

 

 

1

 



4


3

Balance, end of period

 

$

46,039

 

 

$

74,910

 


$ 46,039

$ 74,910

 

 

 

 

 

 

 

 

 









Accumulated other comprehensive loss

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(270

 )

 

$

(266

)


$ (288 )
$ (241 )

Unrealized loss on available-for-sale securities, net of tax 

 

 

(31

 )

 

 

—

(17 )

(2 )

Foreign currency translation adjustment

 

 

(7

 )

 

 

(22

 )

(3 )

(45
 )

Balance, end of period

 

$

(308

 )

 

$

(288

)
$ (308 )
$ (288
 )

 

 

 

 

 

 

 

 

 









Accumulated deficit 

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(2,367

 )

 

$

(23,296

 )
$ (516 )
$ (21,072 )

Net loss

 

 

(1,351

 )

 

 

(1,248

)



(3,202
 )

(3,472
 )

Balance, end of period

 

$

(3,718

 )

 

$

(24,544

)


$ (3,718 )
$ (24,544
 )

 

 

 

 

 

 

 

 

 









Total shareholders' equity

 

$

42,013

 

 

$

50,078

 


$ 42,013

$ 50,078

 

Issue of Common Stock and Warrants


On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.


On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.


Cash Dividend Distribution


On May 8, 2023, the Company announced that the Company’s Board of Directors had declared a special one-time cash dividend of $1.00 per share of the Company’s common stock or eligible warrants and paid $28,978 of cash dividends on May 31, 2023 to shareholders of record on May 22, 2023. 

Nasdaq Delisting Notification

On August 1, 2023, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing management that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was granted a period of 180 calendar days from August 1, 2023, or until January 29, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company’s common stock has continued to trade below $1.00 per share.


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)


9. Debt

Senior Convertible Notes and Warrants 


On December 17, 2019, the Company completed the issuance and sale of $3,000 aggregate principal amount of secured convertible notes of the Company (the “Notes”) and warrants (the “Warrants”) to purchase 340,909 shares of common stock, par value $0.001 per share of the Company (the “Common Stock”), in a private placement transaction. The Notes and Warrants were issued and sold to Edward D. Bagley, an affiliate of the Company, on the terms and conditions of a Note Purchase Agreement dated December 8, 2019 between the Company, certain subsidiary guarantors of the Company, and Mr. Bagley. Mr. Bagley was the beneficial owner of approximately 46.6% of the Company’s issued and outstanding shares of Common Stock at the time that the Notes and Warrants were issued to him.

 

The Notes will mature on December 17, 2023 (the “Maturity Date”) and will accrue interest at a variable rate adjusted on a quarterly basis and equal to two and one-half percent (2.5%) over the greater of (x) five and one-quarter percent (5.25%) and (y) the Prime Rate as published in the Wall Street Journal (New York edition) as of the beginning of such calendar quarter.  The Notes may be converted into shares of the Company’s Common Stock at any time at the election of Mr. Bagley at an initial conversion price of $2.11 per share (the “Conversion Price”), or 120% of the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market. Also, the Company can cause a mandatory conversion of the Notes if the volume weighted average closing price of the Common Stock over 90 consecutive trading days exceeds 200% of the Conversion Price. In addition, the Notes may be redeemed by the Company for cash at any time after December 17, 2020 upon payment of the outstanding principal balance of the Notes and any unpaid and accrued interest.  The Company also is required to redeem the Notes upon the occurrence of a change in control of the Company.

 

The Warrants have an initial exercise price equal to $1.76, the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market, and are exercisable until December 17, 2026.  The Warrants must be exercised for cash, unless at the time of exercise there is not a then effective registration statement for the resale of the shares of Common Stock issuable upon exercise of the Warrants, in which case the Warrants may be exercised via a cashless exercise feature that provides for net settlement of the shares of Common Stock issuable upon exercise. 

 

Concurrent with the issuance of the Notes and Warrants pursuant to the Note Purchase Agreement, the Company, the Guarantors and Mr. Bagley entered into a Guaranty and Collateral Agreement (the “Collateral Agreement”) pursuant to which the Company and the Guarantors granted Mr. Bagley a first priority lien interest in all of the Company’s assets as security for the Company’s performance of its obligations under the Notes and Warrants.

 

The net proceeds after original issue discount and issuance costs of $346 were approximately $2,654. The Company expected to use the proceeds from the sale of the Notes and Warrants for general corporate purposes and working capital. 

 

In accounting for the issuance of the Notes, the Company separated Notes and Warrants into liability and equity components. The carrying amount of Warrants, being an equity component, was first calculated using Black-Scholes method with the following assumptions:


Risk-free interest rate

1.82%

Expected life of warrants (years)

7

Expected price volatility

49.4%

Expected dividend yield

0%

The carrying amount of the Notes was then determined by deducting the fair value of the Warrants from the principal amount of the Notes. The carrying amount of the Notes was further separated into equity and liability components after separating the value of the conversion feature into an equity component and leaving the remaining value as liability. The equity component is not remeasured while the Notes and Warrants continue to meet the conditions for equity classification for equity components.

The original issue discount and issuance costs are netted against the liability. The following table represents the carrying value of Notes and Warrants: 


 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Liability component:

 

 

 

 

 

 

 

 

Principal

 

$

1,245

 

 

$

1,920

 

Less: debt discount and issuance costs, net of amortization

 

 

(41

 )

 

 

(188

)

Net carrying amount

 

$

1,204

 

 

$

1,732

 

Equity component(1):

 

 

 

 

 

 

 

 

Warrants

 

$

318

 

 

$

318

 

Conversion feature

 

122

 

 

122

 

Net carrying amount

 

$

440

 

 

$

440

 










Current portion of liability component included under short-term debt
$ 1,245

$ 1,920
Liability component total
$ 1,245

$ 1,920

(1) Recorded on the condensed consolidated balance sheets as additional paid-in capital. 


Debt discount and issuance costs are amortized over the life of the note to interest expense using the effective interest method. During the three and nine months ended September 30, 2023 amortization of debt discount and issuance costs was $49 and $147, respectively and for the three and nine months ended September 30, 2022 amortization of debt discount and issuance costs was $49 and $147, respectively. The following table represents schedule of maturities of principal amount contained in the Notes as of September 30, 2023:


Year ending December 31,

 

Principal Amount Maturing

 

2023 (Remainder)

 

 

1,245

 

Total principal amount

 

$

1,245

 


Short-term Bridge Loans


On July 2, 2021, the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2021 Bridge Loan”), an affiliate of the Company. The Bridge Loan was evidenced by a promissory note dated July 2, 2021 (the “Note”) issued by the Company to Mr. Bagley.  The Note bore interest at a rate of 8.0% per annum. On September 11, 2021, the Company amended and restated the terms of the Bridge Loan to extend the latest maturity date from October 1, 2021 to January 3, 2022. All other terms and conditions of the Bridge Loan remained the same. On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, pursuant to which the Company issued and sold to Mr. Bagley, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares was the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.


On October 28, 2022 the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2022 Bridge Loan”), an affiliate of the Company. The 2022 Bridge Loan was evidenced by a promissory note dated October 28, 2022 (the “2022 Note”) issued by the Company to Mr. Bagley. The 2022 Note bore interest at a rate of 12.0% per annum and had a maturity date of October 28, 2023. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder. This Bridge Loan of $2,000 is included under short-term debt as of December 31, 2022. In January 2023, the 2022 Bridge loan of $2,000 along with applicable interest was repaid in full.

 

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

 

10. Share-based Compensation

 

As of September 30, 2023, the Company had 218,810 options with contractual lives of ten years and 393,229 options with contractual lives of six years offered under the Company’s 2007 Equity Incentive Plan (the “2007 Plan”), which was restated and approved by the shareholders on December 12, 2015. As of September 30, 2023, the 2007 Plan had 852,815 authorized unissued options.

 

The Company uses judgment in determining the fair value of the share-based payments on the date of grant using an option-pricing model with assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the risk-free interest rate of the awards, the expected life of the awards, the expected volatility over the term of the awards, and the expected dividends of the awards. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based payments granted under the guidelines of ASC Topic 718. 

 

In applying the Black-Scholes methodology to 160,000 options granted in June 2023, the Company used the following assumptions: 

 

Risk free interest rate, average

3.91%

Expected option life, average

5 years

Expected price volatility, average

91.47%

Expected dividend yield

0%

 

A summary of the stock option activity under the Company’s plans for the nine months ended September 30, 2023, is as follows:


 

 

Number of shares

 

 

Weighted average exercise price

 

Options outstanding at beginning of year

 

 

488,477

 

 

$

6.48

 

Granted

 

 

160,000

 

 

 

1.01

 

Less:

 

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

—

 

Forfeited prior to vesting

 

 

(5,210

 )

 

 

2.50

 

Canceled or expired

 

 

(31,228

 )

 

 

7.63

 

Options outstanding at September 30, 2023

 

 

612,039

 

 

 

5.03

 

Options exercisable at end of September 30, 2023

 

 

391,537

 

 

$

7.06

 

 

As of September 30, 2023, the total remaining unrecognized compensation cost related to non-vested stock options, net of forfeitures, was approximately $186, which will be recognized over a weighted average period of 2.42 years.

 

Share-based compensation expense has been recorded as follows: 

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of goods sold

 

$

2

 

 

$

2

 

 

$

5

 

 

$

6

 

Sales and marketing

 

 

2

 

 

 

2

 

 

 

6

 

 

 

9

 

Research and product development

 

 

17

 

 

 

10

 

 

 

37

 

 

 

34

 

General and administrative

 

 

12

 

 

 

10

 

 

 

32

 

 

 

40

 

 

 

$

33

 

 

$

24

 

 

$

80

 

 

$

89

 


 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

11. Income Taxes

 

The current year loss did not result in income tax benefit due to recording a full valuation allowance against expected benefits. The valuation allowance was recorded as we concluded that it was more likely than not that our deferred tax assets were not realizable primarily due to the Company's recent pre-tax losses. Provision for income taxes for the nine months ended September 30, 2023 mostly represents income tax expense recorded for jurisdictions outside the United States.


The Company had approximately $962 of uncertain tax positions as of September 30, 2023. Due to the inherent uncertainty of the underlying tax positions, it is not possible to forecast the payment of this liability for any particular year.


12. Fair Value Measurements

 

The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels: 

 

Level 1 - Quoted prices in active markets for identical assets and liabilities. 

 

Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. This category generally includes U.S. Government and agency securities; municipal securities; mutual funds and securities sold and not yet settled.

 

Level 3 - Unobservable inputs.

 

The Company’s financial instruments are valued using observable inputs. The following table sets forth the fair value of the financial instruments re-measured by the Company as of September 30, 2023:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds

 

$

1,171

 

 

$

—

 

 

$

—

 

 

$

1,171

 

US Treasury securities

 


—

 

 


3,278

 

 


—

 

 


3,278

 

Certificates of deposit

 


—

 

 


859

 

 


—

 

 


859

 

Corporate bonds and notes

 

 

—

 

 

 

973

 

 

 

—

 

 

 

973

 

Total

$

1,171

$

5,110

$

—

$

6,281

 

There were no financial instruments that were re-measured by the Company as of December 31, 2022.

 

13. Subsequent events

 

None.



 

This report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, product recalls and product liability claims; infringement of our technology or assertion that our technology infringes the rights of other parties; termination of supplier relationships, or failure of suppliers to perform; our expectations regarding the ongoing transition of manufacturing of our products from China to Singapore by our electronics manufacturing services provider; inability to successfully manage growth; delays in obtaining regulatory approvals or the failure to maintain such approvals; concentration of our revenue among a few customers, products or procedures; development of new products and technology that could render our products obsolete; market acceptance of new products; introduction of products in a timely fashion; price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of our common stock; foreign currency fluctuations; changes in key personnel; work stoppage or transportation risks; integration of business acquisitions; and other factors referred to in our reports filed with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2022. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Part II, Item 1A “Risk Factors” in this Quarterly Report on Form 10-Q and in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022

 

BUSINESS OVERVIEW

 

ClearOne is a global Company that designs, develops and sells conferencing, collaboration, and AV networking solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer a high level of functionality, reliability and scalability. We derive a major portion of our revenue from audio conferencing products and microphones by promoting our products in the professional audio-visual channel. We have extended our total addressable market from the installed audio conferencing market to adjacent complementary markets – microphones, video collaboration and AV networking. We have achieved this through strategic technological acquisitions as well as by internal product development. 

 

On January 30, 2023, we introduced the new CHAT® 150 BT group speakerphone with USB and Bluetooth connectivity that enhances the conferencing experience for the ultimate in business class performance. With simple, instant connection to personal computers, mobile devices or Bluetooth-enabled desk phones, the CHAT® 150 BT group speakerphone provides users with an affordable way to upgrade home offices, executive offices, and mid-size meeting rooms with BYOD convenience and superior audio clarity for audio conferences and video meetings. The CHAT® 150 BT speakerphone also has an audio bridging feature that allows far end conference participants connected via a software conferencing application through USB, local users of the speakerphone, and far end callers on a mobile call connected through Bluetooth to all join the same call and hear each other clearly. Featuring a steerable microphone array with first-mic priority, the CHAT® 150 BT speakerphone intelligently activates the microphone closest to the person speaking, reducing interference from ambient noise. Like all ClearOne microphone products, the CHAT® 150 BT speakerphone is compatible with popular collaboration platforms including Microsoft® Teams, Zoom™, WebEx™, Google® Meet™, and many more. The new BT model retains all the class-leading features of the original CHAT® 150 speakerphone, including Advanced Noise Cancellation, Full Duplex Distributed Echo Cancellation™ and Automatic Level Control algorithms, to ensure highly intelligible, natural audio capture and playback. It also supports NFC tap-to-pair and includes a wired USB connection for compatibility with the full variety of modern devices.


 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


On January 16, 2023, we introduced UNITE 260 Pro camera, a professional grade 4K Ultra HD camera featuring both a 20X optical zoom and 16X digital zoom that allows users to capture every participant in all meeting, training, and learning environments it is deployed in. Compatible with all popular meeting applications like Microsoft® Teams, Zoom™, WebEx™, and Google® Meet™, the new camera features an AI-based smart face tracking mode that keeps a selected presenter in the frame as they move about the room. Alternatively, the camera’s AI-based auto framing mode always keeps an entire group in perfect view. With dual video outputs HDMI and IP, the UNITE 260 Pro Camera is an excellent choice for a hybrid environment: streaming content while simultaneously showing it live where the presentation is occurring.


In May 2023, we launched eight new COLLABORATE® Versa® packaged hardware systems to provide optimized audio and video performance for conference rooms and personal office spaces. The updated lineup of bundled solutions empowers businesses of all sizes and means to leverage powerful conferencing capabilities that include automatic voice tracking, face tracking and echo cancellation. The new lineup of COLLABORATE Versa solutions offers an ideal package for every small-to-medium sized conferencing space or personal office, giving business owners and IT staff mission-specific options that ensure maximum value, utility and performance in any room. The solutions launched were COLLABORATE Versa Room CT 160, COLLABORATE Versa Room CT, COLLABORATE Versa 20, COLLABORATE Versa 20 Plus, COLLABORATE Versa 160, COLLABORATE Versa 60, COLLABORATE Versa Pro 160, and COLLABORATE Versa Pro 60.


In June 2023, we returned to Infocomm for the first time since 2019 with a complete suite of products, programs, and on-site demonstrations designed to help partners grow their business across every vertical market where increased collaboration is a priority. We exhibited our solutions in Booth #3061 in the Orange County Convention Center from June 14-16, 2023 in Orlando, Florida. 


At Infocomm 2023, we unveiled the BMA 360D, the newest member of the world’s most advanced beamforming microphone array ceiling tile family. The BMA 360D offers unrivaled audio performance and native compatibility with any Dante-enabled DSP mixer. The new Dante-compatible beamforming microphone array allows integrators and users to leverage ClearOne’s industry-leading microphone innovations in more projects and spaces than ever before. The BMA 360D takes our groundbreaking product to the next level by leveraging standard IP networking infrastructure in an enterprise, empowering AV and IT practitioners to upgrade existing room solutions to use more powerful microphones and expanding flexibility that enables third-party DSP integrations in new system designs. The added power and advanced beamforming also enhance the performance of critical modern functions such as voice lift and camera tracking. Dante integration in the BMA 360D enhances the array’s functionality by delivering unprocessed beam audio on individual Dante transmit channels. Additionally, a smart-switched output is delivered on a separate Dante channel to provide the optimal mix of active inputs while enabling ClearOne’s full suite of audio enhancements, which include echo cancellation, noise cancellation, and level control. The BMA 360D incorporates the industry’s only ultra-wideband, frequency-invariant beamforming mic array technology with uniform gain response across all frequency bands. With proprietary FiBeam™ and DsBeam™ technology, participants experience natural and full-fidelity audio across all beams and within a single beam. DsBeam delivers superb clarity and intelligibility through unparalleled sidelobe depth below -40 dB, resulting in superior rejection of reverb and noise even in challenging environments. Integrator setup is simplified by convenient preset beam patterns for common room layouts, while custom beam patterns can be created for unique floor plans. Combined with adaptive steering that focuses audio pickup on active speakers, the adjustable beam patterns provide impeccable coverage of every meeting or conference participant. The exceptional accuracy of ClearOne’s beamforming and adaptive steering technologies also enhance the performance of voice lift and camera tracking functions for any attached DSP mixer.


We also introduced at Infocomm, our powerful new DIALOG® UVHF wireless microphone system that combines class-leading flexibility, Power over Ethernet (PoE) simplicity, Dante technology, and up to 350 usable frequencies to offer professional-quality audio conferencing, video collaboration, and sound reinforcement for any size room. The new DIALOG UVHF system offers businesses and institutions a flexible wireless microphone system that can address varying types of audio pickup needs for rooms of virtually any size. With up to 350 available frequencies across 160 MHz of RF range, the system also delivers incredibly robust reception.  Now corporate boardrooms, training rooms, college lecture halls, courtrooms and other multi-use venues can ensure excellent audio pickup quality and meet varying pickup needs with the simplicity of PoE that enables installation virtually anywhere through a single CAT6 ethernet cable. ClearOne’s free support for system design and remote commissioning makes it easier than ever to outfit any presentation space with a professional-quality multi-function audio pickup solution. The DIALOG UVHF system allows integrators, room designers and meeting hosts to address a wide range of audio pickup needs through five lavalier, lanyard and headset-type body microphones, two handheld microphones, a boundary microphone and three gooseneck microphones for podium use. Powering the microphones is simple and efficient, as all models use the same 12-hour off-the-shelf Li-ion battery that can be charged via USB-C or an optional eight-bay network-connected charging dock. Firmware updates can be done over the network, while the transmitters charge. The Dante-enabled system includes an eight-channel Dante Access Point to ensure optimal signal transmission and system reliability, while an optional DIALOG UVHF Dante interface provides eight Euroblock balanced analog outputs, including mixed output, USB audio output and eight GPIOs. The lightweight plenum-rated access point provides versatile mounting options for wall, ceiling, tabletop or pole mounting, including VESA mount holes. The DIALOG UVHF is the only system with a wireless access point that delivers antenna redundancy and diversity, with dual antennas providing spatial and polarization diversity that helps maintain high audio quality in harsh environments. A wired ethernet connection adds the ability to connect management software to the access point via a web browser. Secure RF connections are created using full-time standards-based FIPS 197 AES-256 encryption. ClearOne’s solutions are designed to support all leading collaboration platforms, including Microsoft Teams, Google Meet, GoToMeeting, Zoom and WebEx.

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

In August 2023, we showcased our full range of conferencing, collaboration, and communications solutions at CEDIA 2023 held in Denver, Colorado. During the event, we highlighted the CHAT® 150 BT Speakerphone (USB and Bluetooth speakerphone), Versa® Mediabar™ (video soundbar), UNITE® 60 (4K ePTZ wide-angle tracking camera), COLLABORATE® Versa® Pro CT (product bundle consisting of Huddle DSP and BMA CTH beamforming mic array ceiling tile), COLLABORATE® Versa® Lite CT (USB Plug-N-Play beamforming mic array ceiling tile), and COLLABORATE® Versa® 60 (product bundle consisting of CHAT® 150 USB speakerphone, a UNITE® 60 wide angle 4K ePTZ camera, and a VERSA USB Hub). 


In September 2023, our new DIALOG® UVHF Wireless Microphone System was named a winner in the Higher Education category of the 2023 Tech & Learning Magazine Awards of Excellence. The annual Tech & Learning Awards of Excellence program, conducted by leading educational technology publication Tech & Learning, recognizes innovation in the edtech industry and celebrates the most impressive products and solutions that support learning environments.


We continued our programs to cut costs and to speed up product development that we believe will enable us to get back to a growth path. 

 

Overall revenue decreased by 22% in the third quarter of 2023 when compared to the third quarter of 2022, primarily due to a significant decrease in revenues from audio conferencing category. The revenue decline was partially due to our continued inability to source adequate inventory to meet the demand for professional audio products and BMA due to the ongoing transition of manufacturing of our products from China to Singapore by our electronics manufacturing services provider. The revenue decline was also caused by significantly reduced demand for our products in many regions including USA, Europe, the Middle East and China when compared to 2022-Q3 revenues. We expect the challenges with the manufacturing transition from China to Singapore to resolve in the fourth quarter of 2023 as we have seen improvement in product deliveries in the second and third quarters of 2023 when compared to the first quarter of 2023.  Our revenue performance in 2023-Q3 also was to a small extent impacted negatively due to increased costs associated with the electronic raw materials that have affected the global manufacturing of high tech products. We expect these increased costs in various degrees to continue through 2023 and 2024.


Our gross profit margin decreased to 33.1% during the third quarter of 2023 from 41.0% during the third quarter of 2022. Our gross profit margin decreased to 32.8% during the first nine months of 2023 compared to 38.7% during the first nine months of 2022. Gross Profit margin decreased year over year mainly due to increase in administration and overhead costs as a percentage of revenue and change in the revenue mix of the products.


Net loss increased from $1.2 million in the third quarter of 2022 to $1.4 million in the third quarter of 2023. The increase in net loss was mainly due to (a) a decrease in revenues and associated gross margin, partially offset by (b) a decrease in operating expenses and (c) an increase in interest income. Net loss decreased from $3.5 million for the first nine months of 2022 to $3.2 million for the first nine months of 2023. The decrease was mainly due to (a) a recognition of $1.35 million from a one-time legal settlement of a contract dispute, (b) significant reduction in operating expenses, and (c) increase in interest income, partially reduced by (d) reduced revenue and associated gross margin. 

 

We believe, although there can be no assurance, that we can return to generating operating profits through our strategic initiatives namely product innovation and cost reduction.


Industry conditions

 

We operate in a very dynamic and highly competitive industry which is dominated on the one hand by a few players with respect to certain products like traditional video conferencing appliances while on the other hand influenced heavily by a fragmented reseller market consisting of numerous regional and local players. The industry is also characterized by venture capitalist-funded start-ups and private companies willing to fund cumulative cash losses in order to gain market share and achieve certain non-financial goals. It has become increasingly important to have higher interoperability with other products in the audio visual market as well as certifications from leading video conferencing service providers like Microsoft and Zoom. 

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Economic conditions, challenges and risks

 

The audio-visual products market is characterized by intense competition and rapidly evolving technology. Our competitors vary within each product category. Our installed professional audio conferencing products, which is our flagship product category, continue to be ahead of the competition despite the reduction in revenues. Our strength in this space is largely due to our fully integrated suite of products consisting of DSP mixers, wide range of professional microphone products and video collaboration products. Despite our strong leadership position in the installed professional audio conferencing market, we face challenges to revenue growth due to the limited size of the market, pricing pressures from new competitors attracted to the commercial market due to higher margins, our limited ability to be interoperable with other audio visual products in the market, and the lack of certifications from Microsoft.


Our video products and beamforming microphone arrays, especially highly advanced BMA 360 and BMA-CT are critical to our long-term growth. We face intense competition in this market from well-established market leaders as well as emerging players rich with marketing funds. We expect our strategy of making our products more interoperable with other audio-visual products, continuing to improve the quality of our high-end audio conferencing products and microphones, and offering a wide range of innovative professional cameras will generate high growth in the near future. 

 

We derive a significant portion of our revenue (approximately 56% in the first nine months of 2023) from international operations and expect this trend to continue in the future. Most of our revenue from outside the U.S. is billed in U.S. dollars and is not exposed to any significant currency risk. However, we are exposed to foreign exchange risk if the U.S. dollar is strong against other currencies as it will make U.S. Dollar denominated prices of our products less competitive.

 

In December 2019, a novel strain of coronavirus (“COVID-19”) started spreading from China and was declared a pandemic. The COVID-19 pandemic caused severe global disruptions and had varying impact on our business. The installed audio conferencing market was negatively impacted due to lockdowns, postponement of projects and restrictions on installers to visit commercial sites. On the other hand, COVID-19 generated higher than normal demand in 2020 for our video products and personal conferencing products due to the significant expansion of work-from-home market. The extent of COVID-19’s effect on our operational and financial performance depends on multiple factors including the severity and infectiousness of current and future virus strains, effectiveness of vaccines especially on novel strains of COVID-19, government regulations, etc., all of which are uncertain and difficult to predict.  Supply chain disruptions resulting from COVID-19 have caused significant fluctuations in our costs of goods resulting in a reduction of our gross margins in 2021 and 2022. We expect these fluctuations to continue in 2023. If the pandemic resurfaces to be a severe worldwide health crisis, the disease could have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our common stock.

 

Deferred Product Revenue

 

Deferred product revenue decreased to $38 thousand on September 30, 2023 compared to $63 thousand on December 31, 2022.

 

A detailed discussion of our results of operations follows below.

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Results of Operations for the three and nine months ended September 30, 2023

 

The following table sets forth certain items from our unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2023 (“2023-Q3”) ("2023-YTD") and 2022 ("2022-Q3") ("2022-YTD"), respectively, together with the percentage of total revenue which each such item represents:


   

Three months ended September 30,

Nine months ended September 30,
(dollars in thousands)  

2023

    

2022

     Change Favorable (Adverse) in %

2023

2022

Change Favorable (Adverse) in %

Revenue

   $ 4,889     $ 6,264       (22 )
$ 14,550

$ 21,184

$ (31 )

Cost of goods sold

     3,273       3,694       11

9,771


12,991


25

Gross profit

     1,616     2,570       (37 )

4,779


8,193


(42 )

Sales and marketing

     1,119       1,151       3


3,634


4,273


15

Research and product development

     889       876       (1 )

2,805


3,406


18

General and administrative

     1,097       1,673       34

3,373


5,146


34

Total operating expenses 

     3,105       3,700    
16

9,812


12,825


23

Operating loss

     (1,489 )     (1,130 )     (32 )

(5,033
 )

(4,632 )

(9
 )

Other income (expense), net

     157     (93 )     269

1,877


1,220


54

Loss before income taxes

     (1,332 )     (1,223 )     (9 )

(3,156 )

(3,412
 )

8

Provision for income taxes

     19       25     24

46


60


23

Net loss

   $ (1,351 )   $ (1,248 )     (8 )
$ (3,202
 )
$ (3,472
 )
$ 8

 

Revenue

 

Our revenue decreased to $4.9 million in 2023-Q3 compared to $6.3 million in 2022-Q3 due to a 42% decline in audio conferencing, a 5% decline in microphones, and a 14% increase in video products. Except for BMA and some video products, all other product categories suffered revenue declines year over year. Revenues from BMA and professional audio conferencing products were partially negatively impacted by our inability to source adequate inventory to meet the demand for these products, due to the ongoing transition of manufacturing of our products from China to Singapore by our electronics manufacturing services provider. Our traditional ceiling mics, personal audio conferencing products, and video cameras suffered revenue declines due to lack of demand. During the third quarter of 2023, revenues from Asia including India and the Middle East as a whole increased by 2% while all other regions suffered revenue loss. During 2023-Q3 revenues from Americas declined by 26% and from Europe and Africa declined significantly by 57%. 


During the nine months ended September 30, 2023 our revenues decreased from $21.2 million to $14.6 million compared to the same period in 2022 due to revenues from microphones decreasing by 27%, video products decreasing by 39% and audio conferencing decreasing by 33%.  

 

Costs of Goods Sold and Gross Profit  

 

Cost of goods sold includes expenses associated with finished goods purchased from outsourced manufacturers, the repackaging of our products, our manufacturing and operations organization, property and equipment depreciation, warranty expense, freight expense, royalty payments, and the allocation of overhead expenses.


Our gross profit margin decreased from 41.0% during 2022-Q3 to 33.1% during 2023-Q3. The gross profit margin was negatively impacted due to increases in material costs mainly due to an increase in administration and overhead costs as a percentage of revenue and a negative change in the revenue mix of the products partially offset by reduced inventory obsolescence costs.

 

Our gross profit margin decreased from 38.7% during 2022-YTD to 32.8% during 2023-YTD. The gross profit margin was negatively impacted due to increases in material costs mainly due to an increase in administration and overhead costs as a percentage of revenue and a negative change in the revenue mix of the products partially offset by reduced inventory obsolescence costs.

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Our profitability in the near-term continues to depend significantly on our revenues from professional installed audio-conferencing products. We hold long-term inventory and if we are unable to sell our long-term inventory, our profitability might be affected by inventory write-offs and price mark-downs. Our long-term inventory includes approximately $0.4 million of wireless microphone-related finished goods and assemblies, $0.2 million of Converge Pro and Beamforming microphone array products, $0.9 million of video products, and $1.3 million of raw materials that will be used primarily for manufacturing professional audio conferencing products and BMA microphones. Any business changes that are adverse to these product lines could potentially impact our ability to sell our long-term inventory in addition to our current inventory.

 

Operating Expenses

 

Operating expenses include sales and marketing (“S&M”) expenses, research and product development (“R&D”) expenses and general and administrative (“G&A”) expenses. Total operating expenses in 2023-Q3 was $3.1 million compared to $3.7 million in 2022-Q3. Total operating expenses were $9.8 million for the nine months ended September 30, 2023 compared to $12.8 million for the nine months ended September 30, 2022. The following contains a more detailed discussion of expenses related to sales and marketing, research and product development, general and administrative, and other items. The following contains a more detailed discussion of expenses related to sales and marketing, research and product development, general and administrative, and other items.

Sales and Marketing - S&M expenses include selling, customer service, and marketing expenses such as employee-related costs, allocations of overhead expenses, trade shows, and other advertising and selling expenses.

 

S&M expenses in 2023-Q3 decreased marginally to $1.1 million from $1.2 million for 2022-Q3. The decrease was primarily due to decreases in employment expenses and commissions paid to independent reps partially offset by increases in trade-show related expenses and employees benefit costs.


S&M expenses in the first nine months ended September 30, 2023 decreased to $3.6 million from $4.3 million for nine months ended September 30, 2022. The decrease was primarily due to (a) decreases in employment expenses and consultant expenses due to a reduction in headcount, (b) a decrease in commissions paid to employees and consultants, and (c) a decrease in marketing expenses related to advertising, partially offset by (d) an increase in trade-show related costs.


Research and Product Development - R&D expenses include research and development, product line management, engineering services, and test and application expenses, including employee-related costs, outside services, expensed materials, depreciation, and an allocation of overhead expenses.

 

R&D expenses remained at $0.9 million in 2023-Q3 and 2022-Q3. 


R&D expenses decreased to $2.8 million in the nine months ended September 30, 2023 compared to $3.4 million for the nine months ended September 30, 2022. The decrease was primarily due to (a) a decline in project-related expenses, (b) decreased employment expenses due to a reduction in the headcount, and (c) a decline in allocated expenses, partially offset by (d) an increase in employee benefits and (e) an increase in legal expenses related to securing patents.

  

General and Administrative - G&A expenses include employee-related costs, professional service fees, allocations of overhead expenses, litigation costs, and corporate administrative costs, including costs related to finance and human resources teams.

 

G&A expenses decreased to $1.1 million in 2023-Q3 compared to $1.7 million in 2022-Q3. The reduction was primarily due to (i) a decrease in amortization costs relating to our capitalized patent defense costs, which was fully amortized in 2022-Q4, (ii) a decrease in legal expenses, (iii) and a decrease in employment-related expenses.


G&A expenses decreased to $3.4 million in 2023-YTD compared to $5.1 million in 2022-YTD. The reduction was primarily due to (i) a decrease in amortization costs relating to our capitalized patent defense costs, which was fully amortized in 2022-Q4, (ii) a decline in legal fees, (iii) and a decline in employment-related expenses, partially offset by (iv) an increase in insurance expenses and (v) an increase in investor relations expenses.

 

Interest Expense


Interest expense remained almost the same at $0.1 million in 2023-Q3 and 2022-Q3. Interest expense increased to $0.5 million in 2023-YTD compared to $0.3 million in 2022-YTD primarily due to interest associated with the prepayment of the $2 million bridge loan in January 2023.


 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Other income (expense), net

 

Other income (expense), net includes interest income, foreign currency changes and gain or loss on disposal of assets. Other income for 2023-Q3 included $0.24 million of interest income received on marketable securities. During 2022-Q3 there was no interest income. Other income in 2022-YTD included $1.5 million in gain from the forgiveness of CARES Act Paycheck Protection Program Loan. 2023-YTD included a receipt of $1.34 million from a one-time legal settlement of a contract dispute and $1.0 million of interest income received on marketable securities. All other items not discussed herein included in other income remained immaterial during 2023-YTD, 2022-YTD, 2023-Q3 and 2022-Q3.

 

Provision for income taxes

 

During each of the nine months ended September 30, 2023 and 2022, we did not recognize any benefit from the losses incurred due to setting up a full valuation allowance.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of September 30, 2023, our cash and cash equivalents were approximately $13.7 million compared to $1.0 million as of December 31, 2022. Our working capital was $36.7 million and $69.3 million as of September 30, 2023 and December 31, 2022, respectively. 

 

Net cash provided by operating activities was approximately $51.1 million in the nine months ended September 30, 2023, an increase of net cash provided by operating activities of approximately $53.2 million from $2.1 million of net cash used by operating activities in the nine months ended September 30, 2022. The increase in cash inflow was primarily due to $55 million in receipts from legal settlements, the receipt of $4.5 million from the return of a bond deposited with a court, and a $1.3 million refund of income taxes with interest. These receipts were partially offset by operating losses and $6.7 million in income tax payments.

 

Net cash used in investing activities in the nine months ended September 30, 2023 was $6.8 million compared to $2.3 million of net cash provided by investing activities in the nine months ended September 30, 2022. The increase in cash used in investing activities was primarily due to an increase in purchases of marketable securities (net of sales) by $9.3 million and an increase in purchase of property and equipment by $0.3 million. These increases were partially offset by the elimination of capitalized legal expenses of $0.6 million. 


Net cash used in financing activities in the nine months ended September 30, 2023 was $31.7 million, comprised primarily of dividend distributions of $29.0 million, repayment of the bridge loan of $2.0 million and $0.7 million payments of principal amounts due on senior convertible debt. This compares to $0.5 million used in payments of principal amounts due on senior convertible debt and a receipt of $0.8 million in loan repayments refunded upon forgiveness of CARES Act Paycheck Protection Program loan in the nine months ended September 30, 2022. 

 

As of September 30, 2023, our cash and cash equivalents were approximately $13.7 million compared to $1.0 million as of December 31, 2022. Our working capital was $36.7 million as of September 30, 2023. The Company believes, although there can be no assurance, that the current cash position and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least November 8, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing on favorable terms or at all. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.


As of September 30, 2023, we had open purchase orders of approximately $3.6 million mostly for the purchase of inventory.

 

As of September 30, 2023, we had inventory totaling $11.5 million, of which non-current inventory accounted for $2.9 million. This compares to total inventories of $11.7 million, which includes non-current inventory of $2.7 million as of December 31, 2022.

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Contractual Obligations and Commitments

 

The following table summarizes our contractual obligations as of September 30, 2023 (in millions):

 

 

 

Payment Due by Period

 

 

 

Total

 

 

Less Than

1 Year

 

 

1-3 Years

 

 

3-5 Years

 

 

More than 5

years

 

Senior convertible notes

 

$

1.2

 

 

$

1.2

 

 

$

—

 

 

$

—

 

 

$

—

 

Operating lease obligations

 

 

1.3

 

 

 

0.4

 

 

 

0.6

 

 

 

0.3

 

 

 

—

 

Purchase obligations

 

 

3.6

 

 

 

3.6

 

 

 

—

 

 

 

—

 

 

 

—

 

Total

 

$

6.1

 

 

$

5.2

 

 

$

0.6

 

 

$

0.3

 

 

$

—

 

  

OFF-BALANCE SHEET ARRANGEMENTS

 

We have no off-balance-sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, results of operations or liquidity.   


CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our discussion and analysis of our results of operations and financial position are based upon our unaudited condensed consolidated financial statements included under Item 1 of this Form 10-Q, which have been prepared in conformity with accounting principles generally accepted in the United States. We review the accounting policies used in reporting our financial results on a regular basis. We believe certain of our accounting policies are critical to understanding our financial position and results of operations. There have been no changes to the critical accounting policies as explained in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

For a discussion of recent accounting pronouncements, see Note 1: “Business Description, Basis of Presentation and Significant Accounting Policies” in the notes to our unaudited condensed consolidated financial statements included under Item 1 of this Form 10-Q.


 

Not applicable.

 

 

An evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2023 was performed under the supervision and with the participation of our management, including our Chief Executive Officer and our Principal Financial and Accounting Officer. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures are effective at a reasonable assurance level as of September 30, 2023.

 

There has been no change in the Company's internal control over financial reporting as of September 30, 2023, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting. 

 

 

 

The risk factor set forth below supplements and should be read in conjunction with the risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as previously supplemented by our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023:

 

None.


 

(a) None.


(b) Not applicable.


(c) None. 


 

(a) Not applicable.


(b) Not applicable.

 

 

Not applicable.

 

 

(a) Not applicable.


(b) Not applicable.


(c) Not applicable.

 

 

Item 6. EXHIBITS

 

Exhibit No.

 

Title of Document

 

 

 

31.1

 

Section 302 Certification of Chief Executive Officer (filed herewith)

 

 

 

31.2

 

Section 302 Certification of Principal Financial Officer (filed herewith)

 

 

 

32.1

 

Section 906 Certification of Chief Executive Officer (filed herewith)

 

 

 

32.2

 

Section 906 Certification of Principal Financial Officer (filed herewith)

 

 

 

101.INS

 

XBRL Instance Document (filed herewith) 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema (filed herewith)

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase (filed herewith)

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definitions Linkbase (filed herewith)

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase (filed herewith)

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase (filed herewith)



104.1
The cover page of this Quarterly Report on Form 10-Q, formatted in Inline XBRL.

 


SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

ClearOne, Inc.,

(Registrant)

 

 

 

 

By:

/s/ Derek L. Graham

November 8, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

By:

/s/ Narsi Narayanan

November 8, 2023 

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)

 

 

29

EXHIBIT 31.1

 

CERTIFICATION

 

I, Derek L. Graham, certify that:

 

1.

I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

By:

/s/ Derek L. Graham

November 8, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 


EXHIBIT 31.2

 

CERTIFICATION

 

I, Narsi Narayanan, certify that:

 

1.

I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

By:

/s/ Narsi Narayanan

November 8, 2023

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)

 

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Derek L. Graham, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended September 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

 

 

By:

/s/ Derek L. Graham

November 8, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 


EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Narsi Narayanan, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended September 30, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

 

 

By:

/s/ Narsi Narayanan

November 8, 2023

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)

 

v3.23.3
Document And Entity Information - shares
 9 Months Ended
Sep. 30, 2023
Nov. 07, 2023
Cover [Abstract]    
Entity Registrant Name CLEARONE INC  
Entity Central Index Key 0000840715  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding (in shares)   23,960,684
Entity Shell Company false  
Document Type 10-Q  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock, $0.001  
Trading Symbol CLRO  
Security Exchange Name NASDAQ  
Entity File Number 001-33660  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 5225 Wiley Post Way, Suite 500  
Entity Address, City or Town Salt Lake City  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84116  
Entity Tax Identification Number 87-0398877  
City Area Code (801)  
Local Phone Number 975-7200  
Document Quarterly Report true  
Document Transition Report false  
v3.23.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 13,694 $ 984
Current marketable securities 5,698 0
Legal settlement receivable 0 55,000
Receivables, net of allowance of $326 3,874 3,603
Inventories, net 8,664 8,961
Income tax receivable 6,381 1,071
Prepaid expenses and other assets 3,776 7,808
Total current assets 42,087 77,427
Long-term marketable securities 583 0
Long-term inventories, net 2,870 2,707
Property and equipment, net 590 383
Operating lease - right of use assets, net 1,081 1,047
Intangibles, net 1,794 2,071
Other assets 112 115
Total assets 49,117 83,750
Current liabilities:    
Accounts payable 1,759 1,284
Accrued liabilities 2,340 3,041
Deferred product revenue 38 63
Short-term debt 1,204 3,732
Total current liabilities 5,341 8,120
Operating lease liability, net of current 755 492
Other long-term liabilities 1,008 1,008
Total liabilities 7,104 9,620
Shareholders' equity:    
Common stock, par value $0.001, 50,000,000 shares authorized, 23,960,864 and  23,955,767 shares issued and outstanding, respectively 24 24
Additional paid-in capital 46,015 74,910
Accumulated other comprehensive loss (308) (288)
Accumulated deficit (3,718) (516)
Total shareholders' equity 42,013 74,130
Total liabilities and shareholders' equity $ 49,117 $ 83,750
v3.23.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 326 $ 326
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 23,960,684 23,955,767
Common stock, shares outstanding (in shares) 23,960,684 23,955,767
v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 4,889 $ 6,264 $ 14,550 $ 21,184
Cost of goods sold 3,273 3,694 9,771 12,991
Gross profit 1,616 2,570 4,779 8,193
Operating expenses:        
Sales and marketing 1,119 1,151 3,634 4,273
Research and product development 889 876 2,805 3,406
General and administrative 1,097 1,673 3,373 5,146
Total operating expenses 3,105 3,700 9,812 12,825
Operating loss (1,489) (1,130) (5,033) (4,632)
Interest expense (86) (90) (469) (285)
Other income, net 243 (3) 2,346 1,505
Loss before income taxes (1,332) (1,223) (3,156) (3,412)
Provision for income taxes 19 25 46 60
Net loss $ (1,351) $ (1,248) $ (3,202) $ (3,472)
Basic weighted average shares outstanding (in shares) 23,960,313 23,952,555 23,957,311 23,933,033
Diluted weighted average shares outstanding (in shares) 23,960,313 23,952,555 23,957,311 23,933,033
Basic loss per share (in dollars per share) $ (0.06) $ (0.05) $ (0.13) $ (0.15)
Diluted loss per share (in dollars per share) $ (0.06) $ (0.05) $ (0.13) $ (0.15)
Comprehensive loss:        
Net loss $ (1,351) $ (1,248) $ (3,202) $ (3,472)
Unrealized loss on available-for-sale securities, net of tax (31) 0 (17) (2)
Change in foreign currency translation adjustment (7) (22) (3) (45)
Comprehensive loss $ (1,389) $ (1,270) $ (3,222) $ (3,519)
v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (3,202) $ (3,472)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 709 2,390
Amortization of right-of-use assets 306 449
Share-based compensation expense 80 90
Change of inventory to net realizable value 105 221
Gain recognized on Paycheck Protection Plan Loan forgiveness 0 (1,528)
Gain (loss) on disposal of assets and sale of marketable securities (12) 0
Changes in operating assets and liabilities:    
Receivables (271) 868
Legal settlement receivable 55,000 0
Inventories 29 710
Prepaid expenses and other assets 4,035 2,051
Accounts payable 475 (3,336)
Accrued liabilities (448) (54)
Income taxes receivable (5,310) 0
Deferred product revenue (25) 19
Operating lease liabilities (328) (468)
Net cash provided by (used in) operating activities 51,143 (2,060)
Cash flows from investing activities:    
Purchase of property and equipment (372) (17)
Purchase of intangibles (111) (93)
Capitalized patent defense costs 0 (642)
Proceeds from maturities and sales of marketable securities 3,094 3,008
Purchases of marketable securities (9,389) 0
Net cash provided by (used in) investing activities (6,778) 2,256
Cash flows from financing activities:    
Dividend payment (28,979) 0
Net proceeds from equity-based compensation programs 4 3
Paycheck Protection Program loan refund upon full forgiveness net of loan payments 0 768
Principal payments of debt (2,675) (540)
Net cash provided by (used in) financing activities (31,650) 231
Effect of exchange rate changes on cash and cash equivalents (5) (48)
Net increase in cash and cash equivalents 12,710 379
Cash and cash equivalents at the beginning of the period 984 1,071
Cash and cash equivalents at the end of the period 13,694 1,450
The following is a summary of supplemental cash flow activities:    
Cash paid for income taxes 6,650 68
Cash paid for interest $ 311 $ 140
v3.23.3
Business Description, Basis of Presentation and Significant Accounting Policies
 9 Months Ended
Sep. 30, 2023
Business Description, Basis of Presentation and Significant Accounting Policies  
Business Description, Basis of Presentation and Significant Accounting Policies

1. Business Description, Basis of Presentation and Significant Accounting Policies

 

Business Description:

 

ClearOne, Inc., together with its subsidiaries (collectively, “ClearOne” or the “Company”), is a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.

 

Basis of Presentation:

 

The fiscal year for ClearOne is the twelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated. 

 

These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of September 30, 2023 and December 31, 2022, the results of operations for the three and nine months ended September 30, 2023 and 2022, and the cash flows for the nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 and 2022 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC. 

 

Significant Accounting Policies:

 

The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2022. There have been no changes to these policies during the quarter ended September 30, 2023 that are of significance or potential significance to the Company.


Recent accounting pronouncements: 


In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. CECL estimates of expected credit losses on trade receivables over their life will be required to be recorded at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The Company adopted the standard in its first quarter of 2023. There was no material impact on the results of operations.

 

The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.

  

Liquidity:

 

As of September 30, 2023, our cash and cash equivalents were approximately $13,694 compared to $984 as of December 31, 2022. Our working capital was $36,746 as of September 30, 2023. Net cash provided by operating activities was $51,143 for the nine months ended September 30, 2023, an increase of $53,203 compared to $2,060 of cash used in operating activities for the nine months ended September 30, 2022.  The Company believes, although there can be no assurance, that the current cash position and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least November 8, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing on favorable terms or at all. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.
v3.23.3
Revenue Information
 9 Months Ended
Sep. 30, 2023
Revenue Information  
Revenue Information

2. Revenue Information

 

The following table disaggregates the Company’s revenue into primary product groups:

 

 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Audio conferencing

 

$

1,867

 

 

$

3,201

 


$ 6,484

$ 9,655

Microphones

 

 

2,355

 

 

 

2,475

 



6,239


8,525

Video products

 

 

667

 

 

 

588

 



1,827


3,004

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184

 

The following table disaggregates the Company’s revenue into major regions: 


 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

North and South America 

 

$

2,400

 

 

$

3,251

 


$ 7,353

$ 10,211

Asia Pacific (includes Middle East, India and Australia)

 

 

2,058

 

 

 

2,018

 



5,426


6,560

Europe and Africa

 

 

431

 

 

 

995

 



1,771


4,413

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184
v3.23.3
Loss Per Share
 9 Months Ended
Sep. 30, 2023
Loss Per Share  
Loss Per Share

3. Loss Per Share

 

Loss per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options, warrants and the convertible portion of senior convertible notes are considered to be potential common stock. The computation of diluted earnings (loss) per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. 

 

Basic earnings (loss) per common share is the amount of net earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted earnings (loss) per common share is the amount of earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect. 


The following table sets forth the computation of basic and diluted earnings (loss) per common share:

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Numerator:

















Net loss


$ (1,351 )
$ (1,248 )
$ (3,202 )
$ (3,472)

Denominator:

















Basic weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

Dilutive common stock equivalents using treasury stock method



—


—


—


—

Diluted weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

 

















Basic loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

Diluted loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

 

















Weighted average options, warrants and convertible portion of senior convertible notes outstanding



6,294,994


6,694,433


6,316,137


6,896,803

Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation



6,294,994


6,694,433


6,316,137


6,896,803
v3.23.3
Marketable Securities
 9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

4. Marketable Securities

 

The Company has classified its marketable securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned.

 

The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of securities as of September 30, 2023 were as follows:


 

 

Amortized cost

 

 

Gross unrealized holding gains

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities
$ 3,281

$ —

$ (3 )
$ 3,278
Mutual funds

1,169


2


—

1,171
Certificates of deposit

859


—


—


859

Corporate bonds and notes

 

$

989

 

 

$

—

 

 

$

(16

 )

 

$

973

 

Total available-for-sale securities

 

$

6,298

 

 

$

2

 

 

$

(19

 )

 

$

6,281

 

 

There were no available-for sale securities as of December 31, 2022.


 

 

Amortized cost

 

 

Estimated fair value

 

Due within one year

 

$

5,715

 

 

$

5,698

 

Due after one year through five years

 

 

583

 

 

 

583

 

Due after five years

 

 

—

 

 

 

—

 

Total available-for-sale securities

 

$

6,298

 

 

$

6,281

 

 


Debt securities in an unrealized loss position as of September 30, 2023 were not deemed impaired at acquisition and subsequent declines in fair value are not deemed attributed to declines in credit quality. Management believes that it is more likely than not that the securities will receive a full recovery of par value, although there can be no assurance that such recovery will occur. The available-for-sale marketable securities with continuous gross unrealized loss position for less than 12 months and 12 months or greater and their related fair values were as follows: 

 

 

 

Less than 12 months

 

 

More than 12 months

 

 

Total

 

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

As of September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities

 

$

3,278

 

 

$

(3

 )

 

$

—

 

 

$

—

 

 

$

3,278

 

 

$

(3

 )

Corporate bonds and notes

 

 

973

 

 

 

(16

 )

 

 

—

 

 

 

—

 

 

 

973

 

 

 

(16

 )

Total

 

$

4,251

 

 

$

(19

 )

 

$

—

 

 

$

—

 

 

$

4,251

 

 

$

(19

 )
v3.23.3
Intangible Assets
 9 Months Ended
Sep. 30, 2023
Intangible Assets  
Intangible Assets

5. Intangible Assets

 

Intangible assets as of September 30, 2023 and December 31, 2022 consisted of the following:

 

 

 

Estimated useful lives (years)

 

 

September 30, 2023

 

 

December 31, 2022

 

Tradename

 

 5

to

7

 

 

$

555

 

 

$

555

 

Patents and technological know-how

 

10

to

20

 

 

 

7,164

 

 

 

7,053

 

Proprietary software

 

 3

to

15

 

 

 

2,981

 

 

 

2,981

 

Other

 

 3

to

5

 

 

 

323

 

 

 

323

 

Total intangible assets

 

 

 

 

 

 

 

11,023

 

 

 

10,912

 

Accumulated amortization

 

 

 

 

 

 

 

(9,229

 )

 

 

(8,841

)

Total intangible assets, net

 

 

 

 

 

 

$

1,794

 

 

$

2,071

 

 

The amortization of intangible assets for the three and nine months ended September 30, 2023 and 2022 was as follows: 

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Amortization of intangible assets


$ 141

$ 686

$ 388

$ 2,038

 

The estimated future amortization expense of intangible assets is as follows:

 

Years ending December 31,

 

Amount

 

2023 (Remainder)

 

$

129

 

2024

 

 

255

 

2025

 

 

194

 

2026

 

 

193

 

2027

 

 

63

 

Thereafter

 

 

960

 

Total

 

$  

1,794

 

v3.23.3
Inventories
 9 Months Ended
Sep. 30, 2023
Inventories  
Inventories

6. Inventories

 

Inventories, net of reserves, as of September 30, 2023 and December 31, 2022 consisted of the following:  

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Current:

 

 

 

 

 

 

 

 

Raw materials

 

$

3,210

 

 

$

4,499

 

Finished goods

 

 

5,454

 

 

 

4,462

 

 

 

$

8,664

 

 

$

8,961

 

 

 

 

 

 

 

 

 

 

Long-term:

 

 

 

 

 

 

 

 

Raw materials

 

$

1,302

 

 

$

1,068

 

Finished goods

 

 

1,568

 

 

 

1,639

 

 

 

$

2,870

 

 

$

2,707

 

  

Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales. We expect to sell the above inventory, net of reserves, at or above the stated cost and believe that no loss will be incurred on its sale, although there can be no assurance of the timing or amount of any sales. 

 

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory for three and nine months ended September 30, 2023 and 2022 was as follows:   

 

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory


$ 3

$ 194

$ 105

$ 221
v3.23.3
Leases
 9 Months Ended
Sep. 30, 2023
Leases  
Leases

7. Leases

 

Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods. 

 

Rent expense for three and nine months ended September 30, 2023 and 2022 was as follows: 

 

 

 

Three months ended September 30,


 

Nine months ended September 30,

 

 

2023

 

 

2022


 

2023

2022

Rent expense

 

$

110

 

 

$

169


 

$ 369

$ 518

The Company occupies a 1,350 square-foot facility in Gainesville, Florida under the terms of an operating lease expiring in February 2028. The Gainesville facility is used primarily to support the Company's research and development activities. 

 

The Company occupies a 9,402 square-foot facility in Salt Lake City, Utah under the terms of an operating lease expiring in February 2028. The facility supports the Company's principal administrative, sales, marketing, customer support, and research and product development activities. 

 


The Company occupies a 6,175 square-foot facility in Chennai, India under the terms of an operating lease expiring in August 2024. This facility supports the Company's administrative, marketing, customer support, and research and product development activities. The Company is planning to renew the lease.

 

The Company occupies a 40,000 square-foot warehouse in Salt Lake City, Utah under the terms of an operating lease expiring in April 2025, which serves as the Company's primary inventory fulfillment center.  


Supplemental cash flow information related to leases was as follows: 

 

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

Cash paid for amounts included in the measurement of lease liabilities

 



 

 



 

Operating cash flows from operating leases
$ 378
$ 531
Right-of-use assets obtained in exchange for lease obligations:







Operating leases
$ 341

$ —

 

Supplemental balance sheet information related to leases was as follows:

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Operating lease right-of-use assets

 

$

 1,081

 

 

$

 1,047

 


 








Current portion of operating lease liabilities, included in accrued liabilities
$ 390

$ 641

Operating lease liabilities, net of current portion

 

 

755

 

 

 

492

 

Total operating lease liabilities

 

$

1,145

 

 

$

1,133

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term for operating leases (in years) 

3.56


2.12
Weighted average discount rate for operating leases

6.43 %

5.93 %

  

The following represents maturities of operating lease liabilities as of September 30, 2023:

 

Years ending December 31,

 

 

 

 

2023 (Remainder)

 

$

114

 

2024

 

 

439

 

2025

 

 

272

 

2026

 

 

210

 

2027

 

 

216

 

Thereafter

38

Total lease payments

 

 

1,289

 

Less: Imputed interest

 

 

(144

 )

Total

 

$

1,145

 

v3.23.3
Shareholders' Equity
 9 Months Ended
Sep. 30, 2023
Shareholders' Equity  
Shareholders' Equity

8. Shareholders' Equity

 

 

 

Three months ended September 30,

 


Nine Months Ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

46,003

 

 

$

74,885

 


$ 74,934

$ 72,817

Dividends paid

 


—

 


—

 


(28,979 )
—
Issuance of common stock and warrants, net

 —


—


—


2,000

Share-based compensation expense

 

 

33

 

 

 

24

 



80


90

Proceeds from employee stock purchase plan

 

 

3

 

 

 

1

 



4


3

Balance, end of period

 

$

46,039

 

 

$

74,910

 


$ 46,039

$ 74,910

 

 

 

 

 

 

 

 

 









Accumulated other comprehensive loss

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(270

 )

 

$

(266

)


$ (288 )
$ (241 )

Unrealized loss on available-for-sale securities, net of tax 

 

 

(31

 )

 

 

—

(17 )

(2 )

Foreign currency translation adjustment

 

 

(7

 )

 

 

(22

 )

(3 )

(45
 )

Balance, end of period

 

$

(308

 )

 

$

(288

)
$ (308 )
$ (288
 )

 

 

 

 

 

 

 

 

 









Accumulated deficit 

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(2,367

 )

 

$

(23,296

 )
$ (516 )
$ (21,072 )

Net loss

 

 

(1,351

 )

 

 

(1,248

)



(3,202
 )

(3,472
 )

Balance, end of period

 

$

(3,718

 )

 

$

(24,544

)


$ (3,718 )
$ (24,544
 )

 

 

 

 

 

 

 

 

 









Total shareholders' equity

 

$

42,013

 

 

$

50,078

 


$ 42,013

$ 50,078

 

Issue of Common Stock and Warrants


On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.


On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.


Cash Dividend Distribution


On May 8, 2023, the Company announced that the Company’s Board of Directors had declared a special one-time cash dividend of $1.00 per share of the Company’s common stock or eligible warrants and paid $28,978 of cash dividends on May 31, 2023 to shareholders of record on May 22, 2023. 

Nasdaq Delisting Notification

On August 1, 2023, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing management that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was granted a period of 180 calendar days from August 1, 2023, or until January 29, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company’s common stock has continued to trade below $1.00 per share.
v3.23.3
Debt
 9 Months Ended
Sep. 30, 2023
Debt  
Debt

9. Debt

Senior Convertible Notes and Warrants 


On December 17, 2019, the Company completed the issuance and sale of $3,000 aggregate principal amount of secured convertible notes of the Company (the “Notes”) and warrants (the “Warrants”) to purchase 340,909 shares of common stock, par value $0.001 per share of the Company (the “Common Stock”), in a private placement transaction. The Notes and Warrants were issued and sold to Edward D. Bagley, an affiliate of the Company, on the terms and conditions of a Note Purchase Agreement dated December 8, 2019 between the Company, certain subsidiary guarantors of the Company, and Mr. Bagley. Mr. Bagley was the beneficial owner of approximately 46.6% of the Company’s issued and outstanding shares of Common Stock at the time that the Notes and Warrants were issued to him.

 

The Notes will mature on December 17, 2023 (the “Maturity Date”) and will accrue interest at a variable rate adjusted on a quarterly basis and equal to two and one-half percent (2.5%) over the greater of (x) five and one-quarter percent (5.25%) and (y) the Prime Rate as published in the Wall Street Journal (New York edition) as of the beginning of such calendar quarter.  The Notes may be converted into shares of the Company’s Common Stock at any time at the election of Mr. Bagley at an initial conversion price of $2.11 per share (the “Conversion Price”), or 120% of the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market. Also, the Company can cause a mandatory conversion of the Notes if the volume weighted average closing price of the Common Stock over 90 consecutive trading days exceeds 200% of the Conversion Price. In addition, the Notes may be redeemed by the Company for cash at any time after December 17, 2020 upon payment of the outstanding principal balance of the Notes and any unpaid and accrued interest.  The Company also is required to redeem the Notes upon the occurrence of a change in control of the Company.

 

The Warrants have an initial exercise price equal to $1.76, the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market, and are exercisable until December 17, 2026.  The Warrants must be exercised for cash, unless at the time of exercise there is not a then effective registration statement for the resale of the shares of Common Stock issuable upon exercise of the Warrants, in which case the Warrants may be exercised via a cashless exercise feature that provides for net settlement of the shares of Common Stock issuable upon exercise. 

 

Concurrent with the issuance of the Notes and Warrants pursuant to the Note Purchase Agreement, the Company, the Guarantors and Mr. Bagley entered into a Guaranty and Collateral Agreement (the “Collateral Agreement”) pursuant to which the Company and the Guarantors granted Mr. Bagley a first priority lien interest in all of the Company’s assets as security for the Company’s performance of its obligations under the Notes and Warrants.

 

The net proceeds after original issue discount and issuance costs of $346 were approximately $2,654. The Company expected to use the proceeds from the sale of the Notes and Warrants for general corporate purposes and working capital. 

 

In accounting for the issuance of the Notes, the Company separated Notes and Warrants into liability and equity components. The carrying amount of Warrants, being an equity component, was first calculated using Black-Scholes method with the following assumptions:


Risk-free interest rate

1.82%

Expected life of warrants (years)

7

Expected price volatility

49.4%

Expected dividend yield

0%

The carrying amount of the Notes was then determined by deducting the fair value of the Warrants from the principal amount of the Notes. The carrying amount of the Notes was further separated into equity and liability components after separating the value of the conversion feature into an equity component and leaving the remaining value as liability. The equity component is not remeasured while the Notes and Warrants continue to meet the conditions for equity classification for equity components.

The original issue discount and issuance costs are netted against the liability. The following table represents the carrying value of Notes and Warrants: 

 

 

 

September 30, 2023

 

 

December 31, 2022

 

Liability component:

 

 

 

 

 

 

 

 

Principal

 

$

1,245

 

 

$

1,920

 

Less: debt discount and issuance costs, net of amortization

 

 

(41

 )

 

 

(188

)

Net carrying amount

 

$

1,204

 

 

$

1,732

 

Equity component(1):

 

 

 

 

 

 

 

 

Warrants

 

$

318

 

 

$

318

 

Conversion feature

 

122

 

 

122

 

Net carrying amount

 

$

440

 

 

$

440

 










Current portion of liability component included under short-term debt
$ 1,245

$ 1,920
Liability component total
$ 1,245

$ 1,920

(1) Recorded on the condensed consolidated balance sheets as additional paid-in capital. 


Debt discount and issuance costs are amortized over the life of the note to interest expense using the effective interest method. During the three and nine months ended September 30, 2023 amortization of debt discount and issuance costs was $49 and $147, respectively and for the three and nine months ended September 30, 2022 amortization of debt discount and issuance costs was $49 and $147, respectively. The following table represents schedule of maturities of principal amount contained in the Notes as of September 30, 2023:


Year ending December 31,

 

Principal Amount Maturing

 

2023 (Remainder)

 

 

1,245

 

Total principal amount

 

$

1,245

 


Short-term Bridge Loans


On July 2, 2021, the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2021 Bridge Loan”), an affiliate of the Company. The Bridge Loan was evidenced by a promissory note dated July 2, 2021 (the “Note”) issued by the Company to Mr. Bagley.  The Note bore interest at a rate of 8.0% per annum. On September 11, 2021, the Company amended and restated the terms of the Bridge Loan to extend the latest maturity date from October 1, 2021 to January 3, 2022. All other terms and conditions of the Bridge Loan remained the same. On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, pursuant to which the Company issued and sold to Mr. Bagley, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares was the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.


On October 28, 2022 the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2022 Bridge Loan”), an affiliate of the Company. The 2022 Bridge Loan was evidenced by a promissory note dated October 28, 2022 (the “2022 Note”) issued by the Company to Mr. Bagley. The 2022 Note bore interest at a rate of 12.0% per annum and had a maturity date of October 28, 2023. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder. This Bridge Loan of $2,000 is included under short-term debt as of December 31, 2022. In January 2023, the 2022 Bridge loan of $2,000 along with applicable interest was repaid in full.
v3.23.3
Share-Based Compensation
 9 Months Ended
Sep. 30, 2023
Share-Based Compensation  
Share-Based Compensation

10. Share-based Compensation

 

As of September 30, 2023, the Company had 218,810 options with contractual lives of ten years and 393,229 options with contractual lives of six years offered under the Company’s 2007 Equity Incentive Plan (the “2007 Plan”), which was restated and approved by the shareholders on December 12, 2015. As of September 30, 2023, the 2007 Plan had 852,815 authorized unissued options.

 

The Company uses judgment in determining the fair value of the share-based payments on the date of grant using an option-pricing model with assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the risk-free interest rate of the awards, the expected life of the awards, the expected volatility over the term of the awards, and the expected dividends of the awards. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based payments granted under the guidelines of ASC Topic 718. 

 

In applying the Black-Scholes methodology to 160,000 options granted in June 2023, the Company used the following assumptions: 

 

Risk free interest rate, average

3.91%

Expected option life, average

5 years

Expected price volatility, average

91.47%

Expected dividend yield

0%

 

A summary of the stock option activity under the Company’s plans for the nine months ended September 30, 2023, is as follows:


 

 

Number of shares

 

 

Weighted average exercise price

 

Options outstanding at beginning of year

 

 

488,477

 

 

$

6.48

 

Granted

 

 

160,000

 

 

 

1.01

 

Less:

 

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

—

 

Forfeited prior to vesting

 

 

(5,210

 )

 

 

2.50

 

Canceled or expired

 

 

(31,228

 )

 

 

7.63

 

Options outstanding at September 30, 2023

 

 

612,039

 

 

 

5.03

 

Options exercisable at end of September 30, 2023

 

 

391,537

 

 

$

7.06

 

 

As of September 30, 2023, the total remaining unrecognized compensation cost related to non-vested stock options, net of forfeitures, was approximately $186, which will be recognized over a weighted average period of 2.42 years.

 

Share-based compensation expense has been recorded as follows: 

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of goods sold

 

$

2

 

 

$

2

 

 

$

5

 

 

$

6

 

Sales and marketing

 

 

2

 

 

 

2

 

 

 

6

 

 

 

9

 

Research and product development

 

 

17

 

 

 

10

 

 

 

37

 

 

 

34

 

General and administrative

 

 

12

 

 

 

10

 

 

 

32

 

 

 

40

 

 

 

$

33

 

 

$

24

 

 

$

80

 

 

$

89

 

v3.23.3
Income Taxes
 9 Months Ended
Sep. 30, 2023
Income Taxes  
Income Taxes

11. Income Taxes

 

The current year loss did not result in income tax benefit due to recording a full valuation allowance against expected benefits. The valuation allowance was recorded as we concluded that it was more likely than not that our deferred tax assets were not realizable primarily due to the Company's recent pre-tax losses. Provision for income taxes for the nine months ended September 30, 2023 mostly represents income tax expense recorded for jurisdictions outside the United States.


The Company had approximately $962 of uncertain tax positions as of September 30, 2023. Due to the inherent uncertainty of the underlying tax positions, it is not possible to forecast the payment of this liability for any particular year.
v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Measurements  
Fair Value Measurements

12. Fair Value Measurements

 

The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels: 

 

Level 1 - Quoted prices in active markets for identical assets and liabilities. 

 

Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. This category generally includes U.S. Government and agency securities; municipal securities; mutual funds and securities sold and not yet settled.

 

Level 3 - Unobservable inputs.

 

The Company’s financial instruments are valued using observable inputs. The following table sets forth the fair value of the financial instruments re-measured by the Company as of September 30, 2023:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds

 

$

1,171

 

 

$

—

 

 

$

—

 

 

$

1,171

 

US Treasury securities

 


—

 

 


3,278

 

 


—

 

 


3,278

 

Certificates of deposit

 


—

 

 


859

 

 


—

 

 


859

 

Corporate bonds and notes

 

 

—

 

 

 

973

 

 

 

—

 

 

 

973

 

Total

$

1,171

$

5,110

$

—

$

6,281

 

There were no financial instruments that were re-measured by the Company as of December 31, 2022.
v3.23.3
Subsequent events
 9 Months Ended
Sep. 30, 2023
Subsequent events  
Subsequent events

13. Subsequent events

 

None.
v3.23.3
Business Description, Basis of Presentation and Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2023
Business Description, Basis of Presentation and Significant Accounting Policies  
Basis of Presentation:

Basis of Presentation:

 

The fiscal year for ClearOne is the twelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated. 

 

These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of September 30, 2023 and December 31, 2022, the results of operations for the three and nine months ended September 30, 2023 and 2022, and the cash flows for the nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 and 2022 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC. 
Significant Accounting Policies:

Significant Accounting Policies:

 

The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2022. There have been no changes to these policies during the quarter ended September 30, 2023 that are of significance or potential significance to the Company.


Recent accounting pronouncements: 


In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. CECL estimates of expected credit losses on trade receivables over their life will be required to be recorded at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The Company adopted the standard in its first quarter of 2023. There was no material impact on the results of operations.

 

The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.
Liquidity:

Liquidity:

 

As of September 30, 2023, our cash and cash equivalents were approximately $13,694 compared to $984 as of December 31, 2022. Our working capital was $36,746 as of September 30, 2023. Net cash provided by operating activities was $51,143 for the nine months ended September 30, 2023, an increase of $53,203 compared to $2,060 of cash used in operating activities for the nine months ended September 30, 2022.  The Company believes, although there can be no assurance, that the current cash position and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least November 8, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing on favorable terms or at all. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.
v3.23.3
Revenue Information (Tables)
 9 Months Ended
Sep. 30, 2023
Revenue Information  
Schedule disaggregates the Company’s revenue into primary product groups and major regions

 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Audio conferencing

 

$

1,867

 

 

$

3,201

 


$ 6,484

$ 9,655

Microphones

 

 

2,355

 

 

 

2,475

 



6,239


8,525

Video products

 

 

667

 

 

 

588

 



1,827


3,004

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184

 

 

 

Three months ended September 30,

 


Nine months ended September 30,

 

 

2023

 

 

2022

 


2023

2022

North and South America 

 

$

2,400

 

 

$

3,251

 


$ 7,353

$ 10,211

Asia Pacific (includes Middle East, India and Australia)

 

 

2,058

 

 

 

2,018

 



5,426


6,560

Europe and Africa

 

 

431

 

 

 

995

 



1,771


4,413

 

 

$

4,889

 

 

$

6,264

 


$ 14,550

$ 21,184
v3.23.3
Loss Per Share (Tables)
 9 Months Ended
Sep. 30, 2023
Loss Per Share  
Schedule of the computation of basic and diluted earnings (loss) per common share

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Numerator:

















Net loss


$ (1,351 )
$ (1,248 )
$ (3,202 )
$ (3,472)

Denominator:

















Basic weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

Dilutive common stock equivalents using treasury stock method



—


—


—


—

Diluted weighted average shares outstanding



23,960,313


23,952,555


23,957,311


23,933,033

 

















Basic loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

Diluted loss per common share


$ (0.06 )
$ (0.05 )
$ (0.13 )
$ (0.15)

 

















Weighted average options, warrants and convertible portion of senior convertible notes outstanding



6,294,994


6,694,433


6,316,137


6,896,803

Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation



6,294,994


6,694,433


6,316,137


6,896,803
v3.23.3
Marketable Securities (Tables)
 9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security

 

 

Amortized cost

 

 

Gross unrealized holding gains

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities
$ 3,281

$ —

$ (3 )
$ 3,278
Mutual funds

1,169


2


—

1,171
Certificates of deposit

859


—


—


859

Corporate bonds and notes

 

$

989

 

 

$

—

 

 

$

(16

 )

 

$

973

 

Total available-for-sale securities

 

$

6,298

 

 

$

2

 

 

$

(19

 )

 

$

6,281

 

Schedule of maturities of marketable securities classified as available-for-sale securities

 

 

Amortized cost

 

 

Estimated fair value

 

Due within one year

 

$

5,715

 

 

$

5,698

 

Due after one year through five years

 

 

583

 

 

 

583

 

Due after five years

 

 

—

 

 

 

—

 

Total available-for-sale securities

 

$

6,298

 

 

$

6,281

 

 
Schedule of available-for-sale marketable securities with continuous gross unrealized loss position

 

 

Less than 12 months

 

 

More than 12 months

 

 

Total

 

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

 

Estimated fair value

 

 

Gross unrealized holding losses

 

As of September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Treasury securities

 

$

3,278

 

 

$

(3

 )

 

$

—

 

 

$

—

 

 

$

3,278

 

 

$

(3

 )

Corporate bonds and notes

 

 

973

 

 

 

(16

 )

 

 

—

 

 

 

—

 

 

 

973

 

 

 

(16

 )

Total

 

$

4,251

 

 

$

(19

 )

 

$

—

 

 

$

—

 

 

$

4,251

 

 

$

(19

 )
v3.23.3
Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2023
Intangible Assets  
Schedule of intangible assets and estimated useful lives

 

 

Estimated useful lives (years)

 

 

September 30, 2023

 

 

December 31, 2022

 

Tradename

 

 5

to

7

 

 

$

555

 

 

$

555

 

Patents and technological know-how

 

10

to

20

 

 

 

7,164

 

 

 

7,053

 

Proprietary software

 

 3

to

15

 

 

 

2,981

 

 

 

2,981

 

Other

 

 3

to

5

 

 

 

323

 

 

 

323

 

Total intangible assets

 

 

 

 

 

 

 

11,023

 

 

 

10,912

 

Accumulated amortization

 

 

 

 

 

 

 

(9,229

 )

 

 

(8,841

)

Total intangible assets, net

 

 

 

 

 

 

$

1,794

 

 

$

2,071

 

Schedule of amortization of intangible assets

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Amortization of intangible assets


$ 141

$ 686

$ 388

$ 2,038
Schedule of estimated future amortization expense of intangible assets

Years ending December 31,

 

Amount

 

2023 (Remainder)

 

$

129

 

2024

 

 

255

 

2025

 

 

194

 

2026

 

 

193

 

2027

 

 

63

 

Thereafter

 

 

960

 

Total

 

$  

1,794

 

v3.23.3
Inventories (Tables)
 9 Months Ended
Sep. 30, 2023
Inventories  
Schedule of Inventories, net of reserves

 

 

September 30, 2023

 

 

December 31, 2022

 

Current:

 

 

 

 

 

 

 

 

Raw materials

 

$

3,210

 

 

$

4,499

 

Finished goods

 

 

5,454

 

 

 

4,462

 

 

 

$

8,664

 

 

$

8,961

 

 

 

 

 

 

 

 

 

 

Long-term:

 

 

 

 

 

 

 

 

Raw materials

 

$

1,302

 

 

$

1,068

 

Finished goods

 

 

1,568

 

 

 

1,639

 

 

 

$

2,870

 

 

$

2,707

 

Schedule of net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory

 


Three months ended September 30,

Nine months ended September 30,

 


2023

2022

2023

2022

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory


$ 3

$ 194

$ 105

$ 221
v3.23.3
Leases (Tables)
 9 Months Ended
Sep. 30, 2023
Leases  
Schedule of rent expense

 

 

Three months ended September 30,


 

Nine months ended September 30,

 

 

2023

 

 

2022


 

2023

2022

Rent expense

 

$

110

 

 

$

169


 

$ 369

$ 518
Schedule of Supplemental cash flow and balance sheet information related to leases

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

Cash paid for amounts included in the measurement of lease liabilities

 



 

 



 

Operating cash flows from operating leases
$ 378
$ 531
Right-of-use assets obtained in exchange for lease obligations:







Operating leases
$ 341

$ —

 

 

September 30, 2023

 

 

December 31, 2022

 

Operating lease right-of-use assets

 

$

 1,081

 

 

$

 1,047

 


 








Current portion of operating lease liabilities, included in accrued liabilities
$ 390

$ 641

Operating lease liabilities, net of current portion

 

 

755

 

 

 

492

 

Total operating lease liabilities

 

$

1,145

 

 

$

1,133

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term for operating leases (in years) 

3.56


2.12
Weighted average discount rate for operating leases

6.43 %

5.93 %
Schedule of maturities of operating lease liabilities

Years ending December 31,

 

 

 

 

2023 (Remainder)

 

$

114

 

2024

 

 

439

 

2025

 

 

272

 

2026

 

 

210

 

2027

 

 

216

 

Thereafter

38

Total lease payments

 

 

1,289

 

Less: Imputed interest

 

 

(144

 )

Total

 

$

1,145

 

v3.23.3
Shareholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Shareholders' Equity  
Schedule of changes in stockholders' equity

 

 

Three months ended September 30,

 


Nine Months Ended September 30,

 

 

2023

 

 

2022

 


2023

2022

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

46,003

 

 

$

74,885

 


$ 74,934

$ 72,817

Dividends paid

 


—

 


—

 


(28,979 )
—
Issuance of common stock and warrants, net

 —


—


—


2,000

Share-based compensation expense

 

 

33

 

 

 

24

 



80


90

Proceeds from employee stock purchase plan

 

 

3

 

 

 

1

 



4


3

Balance, end of period

 

$

46,039

 

 

$

74,910

 


$ 46,039

$ 74,910

 

 

 

 

 

 

 

 

 









Accumulated other comprehensive loss

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(270

 )

 

$

(266

)


$ (288 )
$ (241 )

Unrealized loss on available-for-sale securities, net of tax 

 

 

(31

 )

 

 

—

(17 )

(2 )

Foreign currency translation adjustment

 

 

(7

 )

 

 

(22

 )

(3 )

(45
 )

Balance, end of period

 

$

(308

 )

 

$

(288

)
$ (308 )
$ (288
 )

 

 

 

 

 

 

 

 

 









Accumulated deficit 

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(2,367

 )

 

$

(23,296

 )
$ (516 )
$ (21,072 )

Net loss

 

 

(1,351

 )

 

 

(1,248

)



(3,202
 )

(3,472
 )

Balance, end of period

 

$

(3,718

 )

 

$

(24,544

)


$ (3,718 )
$ (24,544
 )

 

 

 

 

 

 

 

 

 









Total shareholders' equity

 

$

42,013

 

 

$

50,078

 


$ 42,013

$ 50,078
v3.23.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2023
Debt  
Schedule of Warrants, Valuation assumptions, Black-Scholes method

Risk-free interest rate

1.82%

Expected life of warrants (years)

7

Expected price volatility

49.4%

Expected dividend yield

0%
Schedule of carrying value of Notes and Warrants

 

 

September 30, 2023

 

 

December 31, 2022

 

Liability component:

 

 

 

 

 

 

 

 

Principal

 

$

1,245

 

 

$

1,920

 

Less: debt discount and issuance costs, net of amortization

 

 

(41

 )

 

 

(188

)

Net carrying amount

 

$

1,204

 

 

$

1,732

 

Equity component(1):

 

 

 

 

 

 

 

 

Warrants

 

$

318

 

 

$

318

 

Conversion feature

 

122

 

 

122

 

Net carrying amount

 

$

440

 

 

$

440

 










Current portion of liability component included under short-term debt
$ 1,245

$ 1,920
Liability component total
$ 1,245

$ 1,920

(1) Recorded on the condensed consolidated balance sheets as additional paid-in capital. 
Schedule of maturities of principal amount contained in the Notes

Year ending December 31,

 

Principal Amount Maturing

 

2023 (Remainder)

 

 

1,245

 

Total principal amount

 

$

1,245

 

v3.23.3
Share-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Compensation  
Schedule of valuation assumptions for applying the Black-Scholes methodology to the options granted under share-based payments

Risk free interest rate, average

3.91%

Expected option life, average

5 years

Expected price volatility, average

91.47%

Expected dividend yield

0%

Schedule of stock option activity

 

 

Number of shares

 

 

Weighted average exercise price

 

Options outstanding at beginning of year

 

 

488,477

 

 

$

6.48

 

Granted

 

 

160,000

 

 

 

1.01

 

Less:

 

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

—

 

Forfeited prior to vesting

 

 

(5,210

 )

 

 

2.50

 

Canceled or expired

 

 

(31,228

 )

 

 

7.63

 

Options outstanding at September 30, 2023

 

 

612,039

 

 

 

5.03

 

Options exercisable at end of September 30, 2023

 

 

391,537

 

 

$

7.06

 

Schedule of share-based compensation expense

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of goods sold

 

$

2

 

 

$

2

 

 

$

5

 

 

$

6

 

Sales and marketing

 

 

2

 

 

 

2

 

 

 

6

 

 

 

9

 

Research and product development

 

 

17

 

 

 

10

 

 

 

37

 

 

 

34

 

General and administrative

 

 

12

 

 

 

10

 

 

 

32

 

 

 

40

 

 

 

$

33

 

 

$

24

 

 

$

80

 

 

$

89

 

v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Measurements  
Schedule of fair value of the financial instruments

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds

 

$

1,171

 

 

$

—

 

 

$

—

 

 

$

1,171

 

US Treasury securities

 


—

 

 


3,278

 

 


—

 

 


3,278

 

Certificates of deposit

 


—

 

 


859

 

 


—

 

 


859

 

Corporate bonds and notes

 

 

—

 

 

 

973

 

 

 

—

 

 

 

973

 

Total

$

1,171

$

5,110

$

—

$

6,281

v3.23.3
Business Description, Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Loss Contingencies [Line Items]      
Cash and cash equivalents $ 13,694   $ 984
Working capital 36,746    
Net cash provided by operating activities 51,143 $ (2,060)  
Increase of cash used in operating activities $ 53,203    
v3.23.3
Revenue Information - Revenue into Primary Product Groups and Major Regions (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue [Line Items]        
Revenue $ 4,889 $ 6,264 $ 14,550 $ 21,184
North and South America [Member]        
Revenue [Line Items]        
Revenue 2,400 3,251 7,353 10,211
Asia Pacific (includes Middle East, India and Australia)        
Revenue [Line Items]        
Revenue 2,058 2,018 5,426 6,560
Europe and Africa [Member]        
Revenue [Line Items]        
Revenue 431 995 1,771 4,413
Audio conferencing [Member]        
Revenue [Line Items]        
Revenue 1,867 3,201 6,484 9,655
Microphones [Member]        
Revenue [Line Items]        
Revenue 2,355 2,475 6,239 8,525
Video products [Member]        
Revenue [Line Items]        
Revenue $ 667 $ 588 $ 1,827 $ 3,004
v3.23.3
Loss Per Share - Computation of Basic and Diluted Earnings (Loss) per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:        
Net loss $ (1,351) $ (1,248) $ (3,202) $ (3,472)
Denominator:        
Basic weighted average shares outstanding (in shares) 23,960,313 23,952,555 23,957,311 23,933,033
Dilutive common stock equivalents using treasury stock method (in shares) 0 0 0 0
Diluted weighted average shares outstanding (in shares) 23,960,313 23,952,555 23,957,311 23,933,033
Basic loss per common share (in dollars per share) $ (0.06) $ (0.05) $ (0.13) $ (0.15)
Diluted loss per common share (in dollars per share) $ (0.06) $ (0.05) $ (0.13) $ (0.15)
Weighted average options, warrants and convertible portion of senior convertible notes outstanding (in shares) 6,294,994 6,694,433 6,316,137 6,896,803
Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation (in shares) 6,294,994 6,694,433 6,316,137 6,896,803
v3.23.3
Marketable Securities - Available-for-sale Securities by Major Security Type (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Marketable Securities [Line Items]    
Amortized cost $ 6,298  
Gross unrealized holding gains 2  
Gross unrealized holding losses (19)  
Estimated fair value 6,281 $ 0
US Treasury securities [Member]    
Marketable Securities [Line Items]    
Amortized cost 3,281  
Gross unrealized holding gains 0  
Gross unrealized holding losses (3)  
Estimated fair value 3,278  
Mutual funds [Member]    
Marketable Securities [Line Items]    
Amortized cost 1,169  
Gross unrealized holding gains 2  
Gross unrealized holding losses 0  
Estimated fair value 1,171  
Certificates of deposit [Member]    
Marketable Securities [Line Items]    
Amortized cost 859  
Gross unrealized holding gains 0  
Gross unrealized holding losses 0  
Estimated fair value 859  
Corporate bonds and notes [Member]    
Marketable Securities [Line Items]    
Amortized cost 989  
Gross unrealized holding gains 0  
Gross unrealized holding losses (16)  
Estimated fair value $ 973  
v3.23.3
Marketable Securities - Maturities of Available-for-sale Securities (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Due within one year, amortized cost $ 5,715
Due after one year through five years, amortized cost 583
Due after five years, amortized cost 0
Total available-for-sale securities, amortized cost 6,298
Due within one year, estimated fair value 5,698
Due after one year through five years, estimated fair value 583
Due after five years, estimated fair value 0
Total available-for-sale securities, estimated fair value $ 6,281
v3.23.3
Marketable Securities - Available-for-sale Marketable Securities in Gross Unrealized Loss Position (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Marketable Securities [Line Items]  
Estimated fair value, less than 12 months $ 4,251
Gross unrealized holding losses, less than 12 months (19)
Estimated fair value, more than 12 months 0
Gross unrealized holding losses, more than 12 months 0
Estimated fair value 4,251
Gross unrealized holding losses (19)
US Treasury securities [Member]  
Marketable Securities [Line Items]  
Estimated fair value, less than 12 months 3,278
Gross unrealized holding losses, less than 12 months (3)
Estimated fair value, more than 12 months 0
Gross unrealized holding losses, more than 12 months 0
Estimated fair value 3,278
Gross unrealized holding losses (3)
Corporate bonds and notes [Member]  
Marketable Securities [Line Items]  
Estimated fair value, less than 12 months 973
Gross unrealized holding losses, less than 12 months (16)
Estimated fair value, more than 12 months 0
Gross unrealized holding losses, more than 12 months 0
Estimated fair value 973
Gross unrealized holding losses $ (16)
v3.23.3
Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 11,023 $ 10,912
Accumulated amortization (9,229) (8,841)
Total 1,794 2,071
Tradename [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 555 555
Tradename [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 5 years  
Tradename [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 7 years  
Patents and technological know-how [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 7,164 7,053
Patents and technological know-how [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 10 years  
Patents and technological know-how [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 20 years  
Proprietary software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 2,981 2,981
Proprietary software [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 3 years  
Proprietary software [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 15 years  
Other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total intangible assets $ 323 $ 323
Other [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 3 years  
Other [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives (in years) 5 years  
v3.23.3
Intangible Assets - Amortization of Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Intangible Assets        
Amortization of intangible assets $ 141 $ 686 $ 388 $ 2,038
v3.23.3
Intangible Assets - Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Intangible Assets    
2023 (Remainder) $ 129  
2024 255  
2025 194  
2026 193  
2027 63  
Thereafter 960  
Total $ 1,794 $ 2,071
v3.23.3
Inventories - Inventories, Net of Reserves (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current:    
Raw materials $ 3,210 $ 4,499
Finished goods 5,454 4,462
Total current inventory 8,664 8,961
Long-term:    
Raw materials 1,302 1,068
Finished goods 1,568 1,639
Total long-term inventory $ 2,870 $ 2,707
v3.23.3
Inventories - Net loss incurred on valuation of inventory (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Inventories        
Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory $ 3 $ 194 $ 105 $ 221
v3.23.3
Leases (Details Textual)
Sep. 30, 2023
ft²
Facility to support, research and development activity [Member] | Gainesville, Florida [Member]  
Lessee, Lease, Description [Line Items]  
Area of real estate property 1,350
Facility to support, principal administrative, sales, marketing, customer support, and research and product development activity [Member] | Salt Lake City, Utah [Member]  
Lessee, Lease, Description [Line Items]  
Area of real estate property 9,402
Facility to support, principal administrative, sales, marketing, customer support, and research and product development activity [Member] | Chennai, India [Member]  
Lessee, Lease, Description [Line Items]  
Area of real estate property 6,175
Warehouse to support, primary inventory fulfillment and repair center [Member] | Salt Lake City, Utah [Member]  
Lessee, Lease, Description [Line Items]  
Area of real estate property 40,000
v3.23.3
Leases - Rent Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases        
Rent expense $ 110 $ 169 $ 369 $ 518
v3.23.3
Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ 378 $ 531
Right-of-use assets obtained in exchange for lease obligations:    
Operating leases $ 341 $ 0
v3.23.3
Leases - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Leases    
Operating lease right-of-use assets $ 1,081 $ 1,047
Operating lease liabilities:    
Current portion of operating lease liabilities, included in accrued liabilities 390 641
Operating lease liabilities, net of current portion 755 492
Total operating lease liabilities $ 1,145 $ 1,133
Weighted average remaining lease term for operating leases (in years) 3 years 6 months 21 days 2 years 1 month 13 days
Weighted average discount rate for operating leases 6.43% 5.93%
v3.23.3
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Leases    
2023 (Remainder) $ 114  
2024 439  
2025 272  
2026 210  
2027 216  
Thereafter 38  
Total lease payments 1,289  
Less: Imputed interest (144)  
Total $ 1,145 $ 1,133
v3.23.3
Shareholders' Equity - Shareholders' Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period     $ 74,130  
Foreign currency translation adjustment $ (7) $ (22) (3) $ (45)
Net loss (1,351) (1,248) (3,202) (3,472)
Balance, end of period 42,013 50,078 42,013 50,078
Common stock and additional paid-in capital [Member]        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period 46,003 74,885 74,934 72,817
Dividends paid 0 0 (28,979) 0
Issuance of common stock and warrants, net 0 0 0 2,000
Share-based compensation expense 33 24 80 90
Proceeds from employee stock purchase plan 3 1 4 3
Balance, end of period 46,039 74,910 46,039 74,910
Accumulated other comprehensive loss [Member]        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period (270) (266) (288) (241)
Unrealized loss on available-for-sale securities, net of tax (31) 0 (17) (2)
Foreign currency translation adjustment (7) (22) (3) (45)
Balance, end of period (308) (288) (308) (288)
Accumulated deficit [Member]        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period (2,367) (23,296) (516) (21,072)
Net loss (1,351) (1,248) (3,202) (3,472)
Balance, end of period $ (3,718) $ (24,544) $ (3,718) $ (24,544)
v3.23.3
Shareholders' Equity - (Details Textual)
Aug. 01, 2023
d
$ / shares
May 08, 2023
USD ($)
Jan. 04, 2022
USD ($)
$ / shares
shares
Sep. 12, 2021
USD ($)
$ / shares
shares
Sep. 30, 2023
$ / shares
Dec. 31, 2022
$ / shares
Shareholders' Equity            
Common stock, par value (in dollars per share)         $ 0.001 $ 0.001
Edward D. Bagley | Bridge Loan            
Shareholders' Equity            
Principal amount of loan obtained | $     $ 2,000,000      
Bridge loan issuance date     Jul. 02, 2021      
Bridge loan amended date     Sep. 11, 2021      
Common Stock            
Shareholders' Equity            
Warrants and Rights Outstanding, Maturity Date         Mar. 15, 2027  
Common stock shares issued | shares       3,623,189    
Common stock, par value (in dollars per share)       $ 0.001    
Offering price (Per share)       $ 2.76    
Proceeds from issuance of common stock, gross | $       $ 10,000,000    
Proceeds from issuance of common stock, net of issuance costs | $       $ 9,288,000    
Common stock shares issued for warrants exercisable | shares       3,623,189    
Exercise price of warrants       $ 2.76    
Minimum Bid Price Requirement, per share $ 1          
Minimum Bid Price Requirement, Threshold Consecutive Trading Days | d 30          
Minimum Bid Price Requirement, grant period 180 days          
Common Stock | Dividend declared            
Shareholders' Equity            
Dividends payable, declared date   May 08, 2023        
Dividends payable, Nature   special        
Number of time of special dividend   1        
Dividends payable | $   $ 28,978        
Dividends payable, date to be paid   May 31, 2023        
Dividends payable, record date   May 22, 2023        
Minimum Bid Price Requirement, per share $ 1          
Common Stock | Securities Purchase Agreement | Edward D. Bagley | Private Placement            
Shareholders' Equity            
Common stock shares issued | shares     1,538,461      
Common stock, par value (in dollars per share)     $ 0.001      
Offering price (Per share)     $ 1.3      
v3.23.3
Debt (Details Textual)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Oct. 28, 2022
USD ($)
Jan. 04, 2022
USD ($)
$ / shares
shares
Jul. 02, 2021
USD ($)
Dec. 17, 2019
USD ($)
d
$ / shares
shares
Jan. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
Sep. 12, 2021
$ / shares
shares
Senior Convertible Notes and Warrants                      
Common stock, par value           $ 0.001   $ 0.001   $ 0.001  
Short-term debt | $           $ 1,204   $ 1,204   $ 3,732  
Bridge Loan                      
Senior Convertible Notes and Warrants                      
Debt instrument maturity date     Oct. 01, 2021                
Extended debt instrument maturity date     Jan. 03, 2022                
Common Stock                      
Senior Convertible Notes and Warrants                      
Common stock shares issued | shares                     3,623,189
Common stock, par value                     $ 0.001
Purchase price (in dollars per share)                     2.76
Warrants, Initial exercise price per share                     $ 2.76
Beneficial owner | Common Stock                      
Senior Convertible Notes and Warrants                      
Beneficial owner of the Company’s issued and outstanding shares of Common Stock       46.60%              
Edward D. Bagley | Bridge Loan                      
Senior Convertible Notes and Warrants                      
Principal amount of loan obtained | $   $ 2,000                  
Promissory note issuance date   Jul. 02, 2021                  
Bridge loan amended date   Sep. 11, 2021                  
Edward D. Bagley | Bridge Loan | Notes Payable                      
Senior Convertible Notes and Warrants                      
Interest rate of the loan 12.00%   8.00%                
Principal amount of loan obtained | $ $ 2,000   $ 2,000             $ 2,000  
Promissory note issuance date Oct. 28, 2022   Jul. 02, 2021                
Debt instrument maturity date Oct. 28, 2023                    
Repayments of short-term debt | $         $ 2,000            
Securities Purchase Agreement | Edward D. Bagley | Private Placement | Common Stock                      
Senior Convertible Notes and Warrants                      
Common stock shares issued | shares   1,538,461                  
Common stock, par value   $ 0.001                  
Purchase price (in dollars per share)   $ 1.3                  
Senior Convertible Notes and Warrants                      
Senior Convertible Notes and Warrants                      
Issuance and sale of secured convertible notes | $       $ 3,000              
Original issue discount and issuance costs | $       346              
Net proceeds after original issue discount and issuance costs | $       $ 2,654              
Amortization of debt discount and issuance costs | $           $ 49 $ 49 $ 147 $ 147    
Senior Convertible Notes and Warrants | Common Stock                      
Senior Convertible Notes and Warrants                      
Warrants to purchase of common stock, shares | shares       340,909              
Common stock, par value       $ 0.001              
Senior Convertible Notes                      
Senior Convertible Notes and Warrants                      
Interest accrual at a variable rate adjusted on a quarterly basis, percent       2.50%              
Published in the Wall Street Journal (New York edition) as of the beginning of such calendar quarter       Prime Rate              
Debt instrument maturity date       Dec. 17, 2023              
Senior Convertible Notes | Greater of                      
Senior Convertible Notes and Warrants                      
Interest accrual at a variable rate adjusted on a quarterly basis, percent       5.25%              
Senior Convertible Notes | Common Stock                      
Senior Convertible Notes and Warrants                      
Senior Convertible Notes, Initial conversion price per share       $ 2.11              
Senior Convertible Notes, Threshold percentage of stock price trigger       120.00%              
Senior Convertible Notes, Threshold consecutive trading days | d       90              
Senior Convertible Notes | Common Stock | Greater of                      
Senior Convertible Notes and Warrants                      
Senior Convertible Notes, Threshold percentage of stock price trigger       200.00%              
Warrants | Common Stock                      
Senior Convertible Notes and Warrants                      
Warrants, Initial exercise price per share       $ 1.76              
v3.23.3
Debt (Schedule Of Warrants Valuation Assumptions) (Details)
Sep. 30, 2023
Risk-free interest rate  
Warrants, Valuation assumptions, Black-Scholes method  
Warrants, assumptions rate 1.82%
Expected life of Warrants  
Warrants, Valuation assumptions, Black-Scholes method  
Expected life of Warrants (years) 7 years
Expected price volatility  
Warrants, Valuation assumptions, Black-Scholes method  
Warrants, assumptions rate 49.40%
Expected dividend yield  
Warrants, Valuation assumptions, Black-Scholes method  
Warrants, assumptions rate 0.00%
v3.23.3
Debt (Schedule of carrying value of Notes and Warrants) (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Liability component:    
Principal $ 1,245  
Equity component:    
Warrants [1] 318 $ 318
Conversion feature [1] 122 122
Net carrying amount [1] 440 440
Secured convertible notes    
Liability component:    
Principal 1,245 1,920
Less: debt discount and issuance costs, net of amortization (41) (188)
Net carrying amount 1,204 1,732
Equity component:    
Current portion of liability component included under short-term debt 1,245 1,920
Liability component total $ 1,245 $ 1,920
[1] Recorded on the condensed consolidated balance sheets as additional paid-in capital.
v3.23.3
Debt (Schedule of maturities of principal amount contained in the Notes) (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Senior Convertible Notes, Principal Amount Maturing  
2023 (Remainder) $ 1,245
Total principal amount $ 1,245
v3.23.3
Share-based Compensation (Details Textual) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options, outstanding 612,039 488,477
Number of shares available for grant 160,000  
Unrecognized compensation cost related to non-vested stock options, net of forfeitures $ 186  
Unrecognized compensation cost related to non-vested stock options, net of forfeitures, weighted average period 2 years 5 months 1 day  
Equity Incentive Plan 2007 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options, outstanding 218,810  
Stock options, expiration period (years) 10 years  
Number of authorized unissued options 852,815  
Equity Incentive Plan 2007 (the “2007 Plan”) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options, outstanding 393,229  
Stock options, expiration period (years) 6 years  
v3.23.3
Share-based Compensation - Black-Scholes Assumptions (Details)
 9 Months Ended
Sep. 30, 2023
Share-Based Compensation  
Risk free interest rate, average 3.91%
Expected option life, average 5 years
Expected price volatility, average 91.47%
Expected dividend yield 0.00%
v3.23.3
Share-based Compensation - Stock Option Activity (Details)
 9 Months Ended
Sep. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of year | shares 488,477
Granted | shares 160,000
Exercised | shares 0
Forfeited prior to vesting | shares (5,210)
Canceled or expired | shares (31,228)
Options outstanding at end of year | shares 612,039
Options exercisable at end of year | shares 391,537
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Options outstanding at beginning of year | $ / shares $ 6.48
Granted | $ / shares 1.01
Exercised | $ / shares 0
Forfeited prior to vesting | $ / shares 2.5
Canceled or expired | $ / shares 7.63
Options outstanding at end of year | $ / shares 5.03
Options exercisable at end of year | $ / shares $ 7.06
v3.23.3
Share-based Compensation - Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stock-based Compensation        
Share-based compensation expense $ 33 $ 24 $ 80 $ 89
Cost of goods sold [Member]        
Stock-based Compensation        
Share-based compensation expense 2 2 5 6
Sales and marketing [Member]        
Stock-based Compensation        
Share-based compensation expense 2 2 6 9
Research and product development [Member]        
Stock-based Compensation        
Share-based compensation expense 17 10 37 34
General and administrative [Member]        
Stock-based Compensation        
Share-based compensation expense $ 12 $ 10 $ 32 $ 40
v3.23.3
Income Taxes (Details - Textual)
$ in Thousands
Sep. 30, 2023
USD ($)
Income Taxes  
Uncertain tax positions $ 962
v3.23.3
Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Fair Value Measurements    
Total $ 6,281 $ 0
Level 1 [Member]    
Fair Value Measurements    
Total 1,171  
Level 2 [Member]    
Fair Value Measurements    
Total 5,110  
Level 3 [Member]    
Fair Value Measurements    
Total 0  
Mutual funds [Member]    
Fair Value Measurements    
Total 1,171  
Mutual funds [Member] | Level 1 [Member]    
Fair Value Measurements    
Total 1,171  
Mutual funds [Member] | Level 2 [Member]    
Fair Value Measurements    
Total 0  
Mutual funds [Member] | Level 3 [Member]    
Fair Value Measurements    
Total 0  
US Treasury securities [Member]    
Fair Value Measurements    
Total 3,278  
US Treasury securities [Member] | Level 1 [Member]    
Fair Value Measurements    
Total 0  
US Treasury securities [Member] | Level 2 [Member]    
Fair Value Measurements    
Total 3,278  
US Treasury securities [Member] | Level 3 [Member]    
Fair Value Measurements    
Total 0  
Certificates of deposit [Member]    
Fair Value Measurements    
Total 859  
Certificates of deposit [Member] | Level 1 [Member]    
Fair Value Measurements    
Total 0  
Certificates of deposit [Member] | Level 2 [Member]    
Fair Value Measurements    
Total 859  
Certificates of deposit [Member] | Level 3 [Member]    
Fair Value Measurements    
Total 0  
Corporate bonds and notes [Member]    
Fair Value Measurements    
Total 973  
Corporate bonds and notes [Member] | Level 1 [Member]    
Fair Value Measurements    
Total 0  
Corporate bonds and notes [Member] | Level 2 [Member]    
Fair Value Measurements    
Total 973  
Corporate bonds and notes [Member] | Level 3 [Member]    
Fair Value Measurements    
Total $ 0  
v3.23.3
Subsequent Events (Details) - Common Stock
Aug. 01, 2023
d
$ / shares
Subsequent Event [Line Items]  
Minimum Bid Price Requirement, per share | $ / shares $ 1
Minimum Bid Price Requirement, Threshold Consecutive Trading Days | d 30
Minimum Bid Price Requirement, grant period 180 days
ClearOne (NASDAQ:CLRO)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more ClearOne Charts.
ClearOne (NASDAQ:CLRO)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more ClearOne Charts.